Kamran Abbasi is a doctor, journalist, editor, and broadcaster. Following five years in hospital medicine, in various medical specialties such as psychiatry and cardiology, he worked at The BMJ from 1997 to 2005. He is now back at The BMJ in a new role as executive editor for content, leading the journal's strategic growth internationally, digitally, and in print.
Mohammad Abdolahad was born in Tehran, Iran, in 1982. He received his PhD. In Nanoelectronic Engineering from University of Tehran in 2013 and immediately joined to the university as faculty member in school of electrical and computer engineering. During recent 4 years, he published more than 25 papers and 9 USA Patents in the field of cancer detection by nanoelectronic devices. He introduced CNT-ECIS, SiNW-ECIS, NELMEC, Metas-Chip and CDP as new miniaturized systems for cancer diagnosis. He won the “Best Young Inventor” medal of WIPO in 2016 based on his research and developed systems on technology of cancer diagnosis. He received the “Best Young Scientist from Iran Academy of Science” Also he published the first Iranian paper in “Nature Communications” journal. He published more than 20 USA Patents in the field of technical cancer diagnosis. He is now the coordinator of nanobioelectronic devices lab in UT and Adjoin professor of Tehran university of Medical Sciences.He also supervises more than 5 clinical trial projects on innovative electrical methods in cancer diagnosis and therapies under the ethical certificate of TUMS. He is undergoing to develop the “electro technical oncosurgery” as a new joint Fellowship-Post doc between surgery and electrical engineering disciplines.
H.E. Dr. Jane Ruth Aceng was appointed as the Minister of Health Uganda in June 2016. She is a pediatrics expert and is currently at the level of Senior Consultant Paediatrics. H.E. Dr. Aceng has vast experience both as a manager and a practicing medical personnel, which she accumulated while serving in various capacities as: Medical Officer, Senior Medical Officer, Medical Officer Special Grade, Medical Superintendent, Consultant Pediatrician, Senior Consultant Pediatrician, Hospital Director, and the Director General of Health Services for the Ministry of Health, Uganda.
Dr. Tedros Adhanom Ghebreyesus has been Director-General of the World Health Organization since 2017. Upon assuming office, he outlined five key priorities for the WHO: universal health coverage; health emergencies; women’s, children’s and adolescents’ health; health impacts of climate and environmental change; and a transformed WHO. Tedros is globally recognized as a health scholar, researcher, and diplomat with first-hand experience in research, operations, and leadership in emergency responses to epidemics. He previously served as Ethiopia’s Minister of Foreign Affairs, Ethiopia’s Minister of Health, and Chair of the Board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
Mazda Adli is Director of the Mood Disorders Research Group at the Charité – University Medicine Berlin, Department of Psychiatry and Psychotherapy, and Chair of the Fliedner Klinik Berlin, Centre for Psychiatry, Psychotherapy and Psychosomatic Medicine. He has dedicated his research and personal engagement on strategies to overcome treatment-resistant depression and the treatment of bipolar disorder. Another area of interest is the investigation of modulators of individual stress vulnerability. In addition, he has initiated an interdisciplinary Research Group for Neurourbanism that examines the relation between cities and the mental health of their inhabitants. As executive Director, he was among the cofounders of the World Health Summit until 2012.
Kwaku Agyeman-Manu has been a Member of Parliament for the Dormaa Central Constituency since 2008 and was appointed Minister of Health in 2017. Minister Agyeman-Manu has also served as Ghana's Chairman of the Public Accounts Committee from 2012 to 2016 and was the acting CEO of the National Health Authority in 2006. He also served as the deputy Minister of Finance and Economic Planning under former President John Agyekum Kufuor’s administration. Under the government of President Kufuor, he served as a Deputy Minister of State in the following Ministries: Trade and Industry, Interior, Finance, Communications, and Roads and Transport. He has served on the Boards of institutions such as the Small Arms Commission of Ghana, the Ghana Revenue Authority (GRA), Bank of Ghana, and the Divestiture Implementation Committee.
A trained historian, he is Rector of the Istanbul University and Chairman of the Board of Overseers of the Haliç University.
Dr Ali Akbari Sari is a Professor of Health Policy and Economics, and Dean of School of Public Health at Tehran University of Medical Sciences since 2013. He has got an MD from Tehran University of Medical Sciences (1997), and a PhD in Health Policy from University of York, UK (2006). He is also Associate Editor of Hakim Health Systems Research Journal, advisor of Deputy for Research in Iran Ministry of Health, and Secretary of the Committee for Iran Scientific Medical Journals. He has supervised over 100 postgraduate students and published over 120 papers in peer reviewed journals.
Dr Svetlana Akselrod from the Russian Federation has been appointed Assistant Director-General for Noncommunicable Diseases and Mental Health. She brings more than 15 years of experience in public health coordination and global health diplomacy. Prior to this role, Dr Akselrod was Coordinator at the WHO European Office for the Prevention and Control of Noncommunicable Diseases, where she oversaw WHO’s regional work to prevent and control noncommunicable diseases in eastern Europe and central Asian countries. In addition, she served as Deputy Director of the Department of International Cooperation and Public Affairs within the Ministry of Health of the Russian Federation between 2012 and 2016. In this capacity, she coordinated the government of the Russian Federation's global health engagement in key forums including the G8, G20 and BRICS summits, and the development of health programmes including those focused on noncommunicable in the Asia-Pacific Economic Cooperation (APEC) and Northern European countries. She has served on several global health committees and advisory groups both as a chair and member. In addition, she has represented the Government of the Russian Federation in the WHO Executive Board and for the World Health Assembly. She is trained as a paediatrician and holds a doctorate degree in public health as well as a diploma in international law
Prior to becoming the Minister of Public Health, she was the Managing Director of Hamad Medical Corporation from 2007-2016. Under her leadership, HMC was transformed into an integrated academic health system and has achieved numerous international accreditations and awards. She sits on numerous boards of health related organizations, such as the JCI Middle East Advisory Council, the Association of Academic Health Centers International and the Institute of Global Health Innovation.
Professor Omar Al-Rawas is the Director of the Medical Research Centre at Sultan Qaboos University (SQU), and a Professor and Senior Consultant Pulmonologist at the Department of Medicine of College of Medicine and Health Sciences (COMHS), SQU. His research focuses is on lung function and epidemiology of respiratory conditions, with more than 90 publications in peer-reviewed journals, and many conference presentations and published abstracts. He has previously been the Dean of COMHS - SQU, Chairman of SQUH Board, President of Oman Medical Association, and Chairman of the Health Sector Committee of the Research Council of Oman.
Dr Najeeb Al-Shorbaji has been working as Freelance consultant in knowledge management and eHealth since March 2017. He is the former vice-president for Knowledge, Research and Ethics at eMarefa and the former director of Knowledge, Ethics and Research at WHO. He has worked for WHO in Amman, Alexandria and Cairo as Coordinator and information Scientist. He is currently the President of the eHealth Development Association, a Fellow of the International Academy of Health Sciences Informatics and a member of a number of national, regional and international scientific associations and committees.
Atiye has a Ph.D. in Aeronautics and Astronautics, Nonlinear Dynamics and Control Laboratory from the University of Washington, Seattle. Atiye also holds a MSc in Computer Engineering, Control and Robotics Laboratory from the University of California, Santa Cruz. Atiye brings seven years of experience working on projects from optimal detection of epidemic disease outbreaks to privacy of networks using online optimization algorithms, distributed conflict resolution, and bio-inspired design of a ground robot. Atiye is interested in developing mathematical models for complex disease dynamics which provide accurate inferences from disease surveillance data which will aide in future endeavors for improving and saving people’s lives. As a member of IDM’s team Atiye will be developing a statistical model and optimization algorithm for model calibration and parameter space exploration. These novel methods will be used to generate quantitative results across various disease models.
George Alberti has had a longstanding interest in diabetes and metabolism. He has worked extensively in Tanzania and Mauritius. He has particular interests in the metabolic syndrome and also diagnostic tests for diabetes & has participated in several WHO Expert Committees and working groups relating to diabetes. He has published more than 1100 papers and chapters.
Peter Albiez is the Country Manager of Pfizer Germany. After joining Pfizer in 1996, he held positions of increasing responsibility within sales and marketing. In 2009, Peter was appointed Head of Primary Care and joined the Pfizer Germany Executive Management Board. In March 2015, he was named Country Manager of Pfizer Germany. Peter is actively engaged in professional organizations whose goals reflect his personal beliefs of advancing healthcare and supporting cultural exchange. He is an Advisory Board Member and Cluster Speaker of HealthCapital Berlin-Brandenburg and Chairman of the Regional Board Berlin/Brandenburg of the Association for the Promotion of Humanities and Sciences in Germany. In addition, he is Chairman of the Board of the Society of Friends of the Max Delbrueck Center for Molecular Medicine (MDC). Peter holds a Master of Science in Biology.
Dr. Allali is the principal chief engineer with more than 25 years of experience as official staff member of the Moroccan government, leading member of civil society, and international expert in Climate Change, Environment and Green Economy; providing diverse services as workshop organisation, project evaluation, and preparation of policy and operational financial mechanisms. He is a lead author and leading member of the IPCC Bureau for the preparation of the Third and Fourth Assessment reports (1998-2008). Nobel peace award collaborator of the IPCC in 2007, and founder of the Moroccan association on environment and health since in 2009.
A Professor of Educational Sociology and Labor Market Research, Jutta Allmendinger is a former Director of the Institute of Employment Research (Nuremberg), Professor of Sociology at the Ludwig-Maximilians-University (Munich), and a Fellow at Harvard Business School’s Program for Organizational Behavior (Cambridge). She has authored various monographs and discussion papers, and received several awards for her outstanding work.
Luís de Almeida Sampaio Porto, 1957; Law Degree University Coimbra,1982; Diplomatic Service in 1983; Portuguese Mission NATO,1987; Deputy Director Office NATO’s SG, 1990-1993; Cabinet Portuguese EC Commissioner, 1995-1997; Political Adviser SFOR, Bosnia 1998-1999; Embassy Luanda, 1999-2002; Pres. Development Cooperation, 2003-2004; Ambassador in Algiers, 2004; Ambassador in Belgrade, 2008; Ambassador in Berlin, 2012; Ambassador to NATO, 2015; Pres. Strategic Council CHUC-UC.
After serving as Chair of the Agency’s Board of Governors, Yukiya Amano was Japan's Resident Representative to the Agency from 2005 until his election as Director General in 2009. He has extensive experience in disarmament and non-proliferation diplomacy, as well as nuclear energy issues, and was Director-General for the Disarmament, Non-Proliferation and Science Department at the Japanese Foreign Ministry from 2002-2005.
Dr Amin is a clinician and an educator at the School of Medicine. He is currently the Head of Dept of Neonatology at National University Hospital. He was the Deputy Head of Medical Education Unit and Asst Dean for Curriculum and Assessment. He has authored several books and many articles. He is the recipient of University Teaching Excellence Award(2006), Friends of the Medical Students Award (2008) by the Medical Society, and NUSMed Special Mentor Award (2017).
Dr. Kiarash Aramesh is the director of The James F. Drane Bioethics Institute and a faculty member at the Department of Biology and Health Professions at Edinboro University of Pennsylvania. Before joining the Edinboro University, he worked as a Visiting Scholar at Duquesne University and the National Institutes of Health (NIH). He has also been faculty member at the Medical Ethics and History of Medicine at Tehran University of Medical Sciences in Iran. His research interests include clinical research ethics, global health governance, and the science-pseudoscience debate.
Dr. Marie Archambault received her Doctor of Veterinary Medicine degree from the University of Montreal in 1993. She obtained an MSc in Veterinary Pathology and Microbiology in 1995, a PhD in Microbiology and Immunology in 2000. From 1999 to 2004, she was the head bacteriologist at the Animal Health Laboratory of the University of Guelph where she was also an Adjunct Faculty member. She joined the University of Montreal as a Faculty member in 2004. Her areas of research include antibiotic resistance in veterinary and zoonotic pathogens. Her Natural Sciences and Engineering Research Council of Canada (NSERC) research program is on the investigations into the association between antibiotic resistance and virulence factors of Gram-positive organisms with a focus on Clostridium perfringens. She has also developed a strong research program on Livestock-Associated-Methicillin-Resistant Staphylococcus aureus with the government of Quebec. She is the author/co-author of more than 40 publications in peer-reviewed scientific journals on the topic of antibiotic resistance. She also co-edited the second edition of the Clinical Veterinary Microbiology textbook.
With more than 25 years of experience in public health at national and international levels, Dr Asadi-Lari has served his country, the region and beyond in combating communicable diseases, public health emergencies, non-communicable diseases and health diplomacy in different capacities. As a professor of epidemiology, he has trained and supervised more than 100 postgraduate students, led several national studies such as Urban HEART, and contributed in many national and international research projects. In his position as the DG for International Affairs, he has built up a strong collaboration with the health sectors of more than 90 countries, while playing an important role in International Organizations such as WHO, at regional and global levels, and as a Board Member of the Global Fund, he is responsible for coordinating regional and international activities to fight the three diseases.
Professor Ashby holds the Chair in Medical Statistics and Clinical Trials at Imperial College London, where she is Director of the School of Public Health and formerly Co-Director of Imperial Clinical Trials Unit. Her research interests are in clinical trials, risk-benefit decision making for medicines, and the utility of Bayesian approaches in these areas.
Dr. John Ashton is a graduate of the University of Newcastle and the London School of Hygiene and Tropical Medicine with a background in psychiatry, family medicine and sexual health. He is also a specialist in public health. The author of many scientific papers and books, Dr. Ashton is best known for his work on Health Promotion, Aids prevention, harm reduction and Healthy Cities. Former President of the United Kingdom Faculty of Public Health, he is senior consultant to the WHO European Healthy Cities Network and senior adviser on recovery following the Grenfell Tower fire tragedy in London.
Jorge Atouguia, born in 1956 Infectious Diseases Specialist, Tropical Medicine Specialist, Aviation Medicine Specialist MSc and PhD in Tropical Medicine - NOVA Medical School. Associate Professor - Institute of Hygiene and Tropical Medicine, NOVA Medical School (retired in 2014). President of the Portuguese Society of Traveler's Medicine (2015-) Main research areas: Malaria, Sleeping Sickness, Geohelminths, Arbovirus, Emerging Diseases, Vaccines, and Traveler's Medicine.
From 2006-2013, Professor Atun was Head of the Health Management Group at Imperial College London. From 2008-2012 he served as a member of the Executive Management Team of The Global Fund to Fight AIDS, Tuberculosis and Malaria as the Director of Strategy, Performance and Evaluation Cluster. His research focuses on the design and implementation of health systems transformations and their impact on outcomes.
José is specialized in anesthesiology and in intensive care. His clinical research activities focus on fluid restitution, hemodynamic monitoring, mechanical ventilation, sepsis, patients at high surgical risk and experimental hemodilution.
Michelle Bachelet Jeria assumed her functions as United Nations High Commissioner for Human Rights on September 1, 2018. She is the seventh Commissioner to hold the office, which was established in 1993. Bachelet was previously President of Chile (2006-2010 and 2014-2018), and was the country's first female president. She also served as Chile's Health Minister (2000-2002) an was Latin America’s first female Defense Minister (2002-2004). Prior to her appointment as High Commissioner for Human Rights, Bachelet held a number of UN positions in the areas of women's rights and maternal, newborn, and child health. She has a Medical Degree in surgery, with a specialization in pediatrics and public health.
Dr. Manica Balasegaram is GARDP’s Executive Director and has been instrumental in leading GARDP through its three-year incubation to an independent legal entity, during which time GARDP launched four programmes and built a skilled and dedicated team with expertise from a range of sectors and backgrounds. Manica trained as a medical doctor at the University of Nottingham, UK from where he started his career in internal and emergency medicine. From 2001 onwards, he worked as a doctor and researcher in several countries in Sub- Saharan Africa and Southern Asia. He also gained significant experience working in humanitarian emergencies and responses, largely with Médecins Sans Frontières (MSF). At the end of 2007 he joined the Drugs for Neglected Diseases initiative as Head of Leishmaniasis Clinical Program – a position he held for four years before returning to MSF as Executive Director of their Access Campaign. He was appointed Director of GARDP in June 2016. He is also currently a board member of the Medicines Patent Pool as well as of FIND’s Scientific Advisory Committee. Manica’s experience spans clinical and public health practice in infectious diseases and international work on health policy & access to medicines. He has served on numerous technical and health policy panels and expert groups. He also has substantial experience in conducting and overseeing clinical trials and drug development projects.
Clare Bambra PhD is Professor of Public Health Newcastle University Medical School (UK). Her research focuses on the health effects of labour markets, health and welfare systems, as well as the role of public policies to reduce health inequalities. She has published extensively including How Politics Makes Us Sick: Neoliberal Epidemics (Palgrave Macmillan, 2015) and Health Divides: Where you live can kill you (Policy Press, 2016). She can be followed on Twitter @ProfBambra
MD and Member of the Portuguese National Parliament (Health and Foreign Affairs Committees). Founding President of ‘UNITE – Parliamentarians Network to End HIV/AIDS, Viral Hepatitis and Tuberculosis’, a global platform of policy makers. Globally acknowledged by ‘The Economist’ as a ‘HCV Change Maker’ in recognition of his leadership in the field of hepatitis C. Head of Public Health at Catolica University of Portugal, Coordinator of Sustainable Healthcare at NOVA Information Management School and Guest Lecturer at NOVA Medical School. Founder of ‘CREATING HEALTH – Research and Innovation Funding’. Main author of the book ‘Citizenship for Health'.
Prof. Till Bärnighausen is Director of the Heidelberg Institute of Global Health and an Alexander von Humboldt University Professor. He is a population health researcher who focuses on three areas of research: establishing the causal impacts of large-scale global health interventions – such as HIV treatment, HIV prevention, and childhood vaccination – on health, economic and social outcomes; identifying and testing innovations to improve the delivery of global health interventions through public-sector health systems; and developing new methods for applied population-based health research. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health in the US and a Senior Faculty at the Wellcome Trust’s Africa Health Research Institute (ARHI) in South Africa.
Christian Baron received a Ph.D. in Microbiology at the Ludwig-Maximilians University in Munich in August Böck’s group in the Department of Microbiology in 1993, followed by postdoctoral research with Patricia C. Zambryski at UC Berkeley (CA, USA). In 1997 he returned to Munich as University Assistant to build his independent research group in the Department of Microbiology and in 2002 he was recruited as Associate Professor in the Biology Department at McMaster University in Hamilton (ON, Canada). In 2008 he joined the Department of Biochemistry at the Université de Montréal (QC, Canada) as Full Professor and Chair. In 2015 he was nominated as Vice-Dean of Research and Development at the Faculty of Medicine.
Manoel Barral-Netto, MD. PhD is an investigator at Fundação Oswaldo Cruz (Fiocruz) and currently Vice-President for Education, Information and Communication. For his scientific work he was awarded by UNESCO. He served a Director of the Brazilian Natl Res Council (CNPq). Dr. Barral-Netto is a member of the Brazilian National Academy of Sciences, a Knighter of the National Order of Scientific Merit and a member of the Presidential National Council of Science and Technology.
Dr Gaétan Barrette is Quebec’s Minister of Health and Social Services since 2014. A 1985 graduate in medicine of l’Université de Montréal, Dr Gaétan Barrette became a member of Royal College of Physicians and Surgeons of Canada in 1989. In 1991, he pursued a Fellowship in Vascular and Surgical Radiology at the University of California, San Diego. He currently practises at Maisonneuve-Rosemont hospital where he has been an active member since 1990. Dr. Barrette has been President of the Fédération des médecins spécialistes du Québec between 2006 and 2014. He was also Chairman of the Board of the Financière des professionnels inc. which manages a $2 billion portfolio. He was also a member of the Boards of the Régie de l’assurance maladie du Québec (RAMQ). Dr Barrette participates regularly in various conferences and forums on the subject of specialized medicine throughout Quebec, across Canada and abroad.
Professor of Epidemiology at the Medical School, President of the Institute of Public Health, University of Porto and President of the IEA. Responsible for designing and implementing three on-going Portuguese population-based cohorts following adults(EPiPorto), adolescents(EPITeen) and new-borns(G21); which made possible to train a large number of Master and PhD candidates and resulted in multiple publications covering such topics as obesity, violence and social aspects of ageing.
Declan Barry trained as a paediatrician in Ireland before joining Medicins Sans Frontieres in 2010. With MSF he has worked in many different settings in both clinical and management positions, including Libya 2011, Afghanistan 2012 & 2015, and Syria 2013. He is currently the Medical Coordinator of MSF's response in Greece.
After studying economics he joined Bayer in the Corporate Finance Department. He held several international positions in the company, including member of the Executive Committee and Head of Central Administration & Organization at Bayer HealthCare and Chief Financial Officer of Bayer AG.
Associate professor, School of Industrial Relations, Université de Montréal
Nancy Beauregard, holds a PhD in population health from University of Ottawa. She is an associate professor at the School of Industrial Relations, University of Montreal. She is also a regular researcher at the Institut de recherche en santé publique de l’Université de Montréal (IRSPUM). Nancy Beauregard is interested in the influence of organizational context, and in particular, of the organizational learning process, on occupational health and safety. In addition, her recent work focuses on the association between work injuries and mental health among the workforce. Her researches on at risk industrial sectors and occupations have received financial support from the Institut de recherche Robert-Sauvé en santé et en sécurité du travail (IRSST). Hence, the theme of agricultural health and safety crosses her main research interests.
Jan-Philipp Beck is since February 2018 CEO of EIT Health. He joined EIT Health in 2015 as COO and contributed significantly to developing its structure, system and processes in the establishment phase as well as managing the project portfolio. Prior to this he worked for EY and previously Deloitte where he supported industry, universities and research organisations i. a. with the development and roll-out of R&D. He holds a MA in Political Science, Economics and English from University Tübingen.
After a successful career, she retired from politics in 2003. Since 2006, she has headed Swissmedic, the Swiss supervisory authority for therapeutic products. In 2008, she was appointed permanent Vice-President of the ICRC. Her areas of focus include helping to ensure the cohesion, smooth running and development of governance mechanisms and internal control, as well as strengthening and developing relationships within the International Red Cross and Red Crescent Movement.
Dr. Marcel Behr is Professor of Medicine at McGill University where he is Director of the McGill International TB Centre and Microbiologist-in-Chief of the McGill University Health Centre. His training included BSc (Biochemistry) from the University of Toronto, MD from Queen’s University, Residency training in Infectious Diseases and Medical Microbiology at McGill, an MSc (Epidemiology) from McGill and then post-doctoral studies of Molecular Epidemiology and Bacterial Genomics at Stanford. Dr. Behr’s research interest is the application of bacterial genetics to study the epidemiology and pathogenesis of mycobacterial diseases, specifically, M. tuberculosis, BCG, and non-tuberculous mycobacteria, including members of the M. avium-intracellular complex. This work has been recognized by numerous awards, in Quebec (Chercheur National of the Fonds de la Recherche en Sante du Quebec) and beyond (Fellow of the Canadian Academy of Health Sciences, 2016 and Election to the American Society for Clinical Investigation, 2010).
Klaus M. Beier is in charge of the undergraduate training of medical students in sexual medicine as well as postgraduate training for physicians and psychologists in this field. He is in charge of the outpatient clinic of the institute which offers assessment and treatment of the full range of sexual disorders and gender dysphorias. His current research focuses on the prevention of child sexual abuse.
Professor Robin Bell MBBS (Hons) PhD MPH FAFPHM Grad Cert Health Professional Education. Professor Robin Bell is the Deputy Director of the Women’s Health Research Program in the School of Public Health and Preventive Medicine at Monash University in Melbourne, Victoria, Australia. Professor Bell is a medical epidemiologist specializing in the health of women at midlife and older and has published 180 peer reviewed publications. Professor Bell is also the Curriculum and Assessment Lead for one of the 4 vertical themes in the medical course at Monash, the theme of Society, Population, Health and Illness. Professor Bell teaches population health, health promotion and prevention science as well as a module on the health of women at midlife. Monash University currently has an undergraduate medical course, a post-graduate course and a separate campus with a medical course in Malaysia. There are, in total, about 500 students in each year level of the medical courses at Monash.
Silvana Belo is Assistant Professor in Medical Helminthology/Parasitology at the Instituto de Higiene e Medicina Tropical, UNL since 2000. Pharmacy degree from the University of Coimbra; post-graduate in Clinical Pathology and in Tropical Medicine & Public Health; MSc in Medical Parasitology; PhD in Biomedical Sciences. Researcher and teacher in Medical Helminthology and Parasitology. Head of the Laboratory of immunodiagnostic of Helminthology. Author of various international and national papers.
A physician specialized in tropical medicine and public health, he was one of the founding board members of the Global Fund in 2002 and has served in his current position since 2003. Prior to joining the Global Fund, he worked as a clinician and public health official in the UK, Germany and as Doctor-in-Charge of a rural hospital in Tanzania. He has more than 25 years of experience in global health and health advocacy with a special focus on AIDS and infectious diseases.
Christoph Benn is the Director of External Relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria. He has been responsible for building and maintaining relations with all Global Fund partners and mobilizing resources for the Global Fund almost since its creation in 2002. In this role, he has been managing the replenishment conferences, securing long-term commitments from donors and spearheading innovative approaches to resource mobilization including (Product) RED and Debt2Health.
Seth Berkley is Gavi’s CEO and d medical doctor specializing in infectious disease epidemiology. He founded the International AIDS Vaccine Initiative (IAVI) in 1996, where he served as President and CEO. Prior to that, he worked for the Health Sciences Division at The Rockefeller Foundation, held posts at the Center for Infectious Diseases, the US Centers for Disease Control; the Massachusetts Department of Public Health; and the Carter Center, where he was assigned as an epidemiologist to the Ministry of Health in Uganda.
Formally the Senior Vice President and CFO for Philips Home Healthcare Solutions, he joined Philips from Baxter Healthcare, where he acted as the European Regional Controller. He accumulated more than 20 years of experience in the healthcare industry, recently completing about 25 M&A transactions with a particular focus on targets in the areas of Home Healthcare, Clinical Decision Support, Imaging and Image Guided Intervention and Treatment.
Victoria is Chair of the Australian Medical Students’ Association, a graduate of Monash University, and is a junior doctor at the Alfred Hospital in Melbourne. She has been heavily involved in medical leadership and particularly in the wellbeing and rights of medical students. She has advocated locally, nationally and internationally for the mental health of medical students as President of the Monash University Medical Society where she worked on bullying advocacy as well as whistleblowing and reporting procedures. On an international level, Victoria worked as the inaugural Mental Health Program Coordinator for the International Federation of Medical Students’ Associations, discussing experiences with and creating tools for students from around the world.
She is passionate about non-formal education in the medical curriculum and believes that to learn broadly and with enthusiasm in fields beyond medicine will make students more holistic, empowered, people-focussed doctors, with greater influence to enact change within our societies.
Since January 2012, Alain Berset has been a member of the Swiss Federal Council, the seven-member Swiss government, and head of the Federal Department of Home Affairs. He studied political science and economics, and has authored several books on economic development, migration and regional development.
Dr. Peter Beyer, a trained lawyer, is a senior WHO advisor responsible for all issues related to intellectual property and public health. He provides legal and technical advice and training to WHO headquarters and Member States. Previously, he was a Legal Advisor to the Swiss Federal Institute of Intellectual Property in Bern. He negotiated bilateral free trade agreements for the European Free Trade Association (EFTA), including with Algeria, the Golf Cooperation Council and South Korea and headed negotiations at WHO and WIPO. Furthermore, he was responsible for the bilateral dialog between Switzerland and China as well as all matters related to intellectual property rights and public health, development and human rights.
Mukul Bhola is Chief Executive of The Defeat-NCD Partnership. A serial entrepreneur, Mukul has more than 19 years of experience as a passionate humanitarian and development practitioner, during which he has led crisis response operations, developed strategic public-private partnerships, and mobilized significant financial resources. Prior to founding The Defeat-NCD Partnership, Mukul headed the Geneva Liaison Office for the Partnerships Group at UNOPS and was also responsible for managing the UNOPS-DFID partnership–growing it to an unprecedented US $250 million of new programmes signed in 2018. Mukul began his United Nations career with the United Nations Information Centre in New Delhi, India in 2000, before moving on to work with the United Nations Development Programme on the Gujarat Earthquake recovery programme, and subsequently its Bureau for Crisis Prevention and Recovery. He co-led – on behalf of the International Labour Organization – four joint United Nations-World Bank post-disaster needs assessments to Bangladesh, Haiti, Madagascar, and Myanmar, and while at the International Labour Organization was seconded to United Nations International Strategy for Disaster Reduction to develop the first biennial joint work programme for the strengthened UNISDR system. With a first-class honours degree in economics, Mukul is highly experienced in working with big data. He spent over five years at the International Federation of Red Cross and Red Crescent Societies. Mukul is a volunteer and life member of the Indian Red Cross, and in 2017 he was requested to support the co-development of their transformational Strategy 2030.
Siamak Bidel MD, PhD, Medical Doctor and Epidemiologist, Senior Researcher working for more than 20 years in medical practice and research.Currently working as a senior researcher, Department of Public Health, University of Helsinki, and Diabetes Unit, National Institute for Health and Welfare (THL), and as a clinician city of Helsinki health care system, Helsinki, Finland. Published many articles, book chapters, and commentary in the international level. Research interests include the epidemiology and prevention of non-communicable diseases such as diabetes, cardiovascular diseases and so on.
Dr Kesete served as Minister of Health of the Federal Democratic Republic of Ethiopia from 2012 to 2016. Dr Kesete has dedicated his career to public service and scientific research focused on major public health problems in Ethiopia and has received numerous national and international awards. A medical doctor by training with a Masters degree in public health, Dr Kesete has served in a number of clinical and public health positions.
Elizabeth Blackburn won the 2009 Nobel Prize in Physiology or Medicine for discovering the molecular nature of telomeres and the co-discovery of telomerase. Both telomeres and telomerase are thought to play central roles in aging and diseases such as cancer. She has shown an abiding commitment to public service in the scientific, academic and public policy arenas, and helped to guide public science policy.
Karl Blanchet is the Director of Health in Humanitarian Crises Centre. He has a background in public health and extensive experience in conflicts areas and health system strengthening in Asia and Africa. Dr. Blanchet is currently the Lead Academic for the development of the Integrated Package of Essential Services in Afghanistan.
Carlos Blanco, M.D., Ph.D., M.S. is the Director of the Division of Epidemiology, Services, and Prevention Research at the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Dr. Blanco is a national known expert in the epidemiology and treatment of addictive disorders with and without comorbid disorders. His accomplishments include, among others, a detailed examination of the course and stages of substance use disorders, the development of methods to quantify the generalizability of clinical trials, the development and testing of interventions that combine motivational interviewing with cognitive-behavioral therapy to improve retention and outcome in individuals with addictive disorders, and the creation of a virtual map of psychiatric disorders, based on empirical data, to guide research into the causes of mental disorders. Prior to joining NIDA, Dr. Blanco was Professor of Psychiatry at Columbia University Medical Center and a Research Psychiatrist at the New York State Psychiatric Institute.
Teodor Cristian Blidaru is a 5th year medical student from Romania, currently serving as the Liaison Officer to Student Organizations of the International Federation of Medical Students’ Associations (IFMSA). Teodor’s work is focused mainly on developing networks of healthcare students coming from interprofessional backgrounds, aiming to increase the impact of youth in Global Health. The main structures Teodor is involved in are the World Health Students’ Alliance and the World Healthcare Students’ Symposium. He is also IFMSA’s focal point and advocate on the topic of Antimicrobial Resistance.
Dr. Blouin serves as Secretary for the Committee on Accreditation of Canadian Medical Schools (CACMS) and for the Committee on Accreditation of Continuing Medical Education (CACME). She still maintains an active academic clinical practice in Emergency Medicine at Queen’s University, and was granted professorship in 2012. In 2003, she completed a Master of Health Professions Education degree at the University of Illinois at Chicago, followed in 2016 by a doctorate degree in Curriculum and Instruction from the same university. She has been involved as an educator and scholar in numerous projects at the provincial, national and international levels. Her research interests centre on curriculum development and program evaluation.
He was previously the Parliamentary Under Secretary of State at the Department of Health, where he was responsible for social services and mental health. Within this role he published guidelines to end the denial of adoptions purely on the basis of race.
Endocrinologist. Endocrinology assistant at the Portuguese Cancer Institute (1988-2008). Endocrinology consultant at the Portuguese Diabetes Association (APDP – Diabetes Portugal). Graduation in Therapeutic Education in Chronic Disease - Geneva University (2002). Clinical Director of the APDP – Diabetes Portugal (2006-2008). President of the Diabetes Education Study Group (DESG) (2006-2011). Director of the National Diabetes Programme (2008-2016). President of the APDP – Diabetes Portugal
Her previous roles at FIND included Chief Medical Officer (CMO) and Head of the TB program, where she was responsible for clinical evaluation of new tools for diagnosis of TB, malaria and neglected diseases. She has an extensive background in clinical evaluation and played a key role in FIND’s Xpert MTB/RIF feasibility. Prior to joining FIND in 2005, she worked as program coordinator for the Department of Infectious and Tropical Diseases in Munich, Germany, and established a TB research unit at Mbeya Medical Research Program in Tanzania.
Dr. Charles Boelen is a medical doctor and international consultant, a specialist in public health (University of Montreal, Canada), epidemiology (McGill University, Montreal), health system management (Harvard and Stanford Universities, USA) and education of health professionals (University of Paris XIII, France). In over 30 years of collaboration with the World Health Organization, he developed health workforce development projects with Ministries of Health and Higher Education, professional associations and academic institutions. He is best known for his work on Social accountability of academic institutions, Primary health workers, the WHO strategy “Towards Unity for Health”.
Hamid Bohloli [MD MPH MRes PhD(Manchester)] is an international advisor, analyser, thinker, strategist and theory builder on public policy and health politics, author of many scientific papers and books. Dr Hamid Bohloli is the author of the book entitled "The Public Policy Process in the Revolutionary Context, with special focus on impact of idea transmision and social evolution on health reform, towards building the theory of Societal Energy. He is also a specialist in governance and health system analysis of developing countries focusing on irregular states. Apart from his scientific field of action he is involved in social networking, lecturing and writing in public media and formal newspapers with thousands of followers to guide public participation in the development path and socialisation of health. Dr Bohloli is best known for his work on reengineering of Ministry of MoHME (1998-2001) and leading the health institutional reform in Iran as a pioneer. He has participated in the Health Reform Flagship Course of the World Bank, Washington Dc.,USA,1998, and designed and conducted many national reform programs and establishing a steering committee of health reform in MoHME. He currently serves as the Chair of International Health and Sustainable Development Department, Secretariat for Supreme Council of Health and Food Security, MoHMe, Iran. He is also a member of Medical Academy and many of national policy advisory boards in the country. Dr Bohloli has the experiences of many years of teaching in social policy and social research methods at the Manchester University and currently is a visiting assistant professor at the Faculty of Law and Political Sciences, Tehran University. He is a member of editorial board at the World Healthcare Journal in the UK, and has been acting as an author and editorial board member of the Public Policy Reference Media in Iran.
An accomplished Corneal Surgeon and Ophthalmologist, Hélène Boisjoly is the first woman to hold the position of Dean of Faculty of Medicine at the University of Montreal and within the greater province of Quebec. She was the International President of the World Health Summit 2017.
MD, Consultant in Gynecology and Obstetrician at Obstetric Service A. Coimbra University Hospital Center. Máster degree on Sexual and Reproductive Health. University of de Alcalá de Henares. Madrid Spain. Collaboration as coordinator and participant on national and international working and research groups on FP and abortion. Author and co-author of publications on Family Planning and Abortion. Member of ESC Expert Group on Sexual and reproductive health and education. Member of Scientific Committee of the European Society of Contraception and Sexual Health.
Elena is responsible to drive strategy and business development for public health and pharma, working together with a community of over 150+ professionals across the region. She spearheaded key initiatives on Health 4.0 and health digital transformation. Mobilizing a core group of industry stakeholders, Elena started the European Cloud in Health Advisory Council, a vendor-neutral C-level forum aimed to foster cloud-first policies. Elena is part of HIMSS Europe Governing Board.
After completing his medical studies in Germany, the specialist for personalized medicine moved to the U.S., where he conducted research at several institutions, among them Massachusetts General Hospital, Harvard Medical School and the National Cancer Institute in Bethesda. He has been the Director of the Biotechnology Center at Albert Einstein College of Medicine in New York, and Director of the Charles Bronfman Institute for Personalized Medicine.
A Professor Emeritus of Public Service, Health Policy and Management, Jo Ivey Boufford served as Dean of the Robert F. Wagner Graduate School of Public Service at New York University and as Principal Deputy Assistant Secretary for Health in the U.S. Department of Health and Human Services (HHS). While at HHS, she served as the U.S. representative on the Executive Board of the World Health Organization (WHO) from 1994–1997.
Jo Ivey Boufford, M.D.is President of the International Society for Urban Health and Clinical Professor of Global Public Health at the College of Global Public Health at New York University. She served as President of The New York Academy of Medicine and Dean of the Robert Wagner Graduate School of Public Service at New York University. She also served as Principal Deputy Assistant Secretary for Health in the U.S. Department of Health and Human Services (HHS) and President of the New York City Health and Hospitals Corporation (HHC). She serves on the boards of the United Hospital Fund, Emblem Health, and the Regional Plan Association. She is Vice Chair of the NYS Public Health and Health Planning Council (PHHPC) and Chair of its Public Health Committee
Jo Ivey Boufford, M.D. is President of the International Society for Urban Health (2017-9) and Clinical Professor of Global Public Health at the College of Global Public Health at New York University. She served as President of The New York Academy of Medicine (2007-2017) and Dean of the Robert F. Wagner Graduate School of Public Service at New York University (1997-2002. Prior to that, she served as Principal Deputy Assistant Secretary for Health in the U.S. Department of Health and Human Services (HHS) from November 1993 to January 1997, and as Acting Assistant Secretary from January 1997 to May 1997. She served in a variety of senior positions in (1982-1985) and as President of the New York City Health and Hospitals Corporation (HHC) (1985-1989). Locally, she serves on the boards of the United Hospital Fund, Emblem Health, and the Regional Plan Association. She is Vice Chair of the NYS Public Health and Health Planning Council (PHHPC) and Chair of its Public Health Committee. She was elected to membership in the US National Academy of Medicine (formerly IOM) in 1992. She is a Fellow of the New York Academy of Medicine. Dr. Boufford received her BA (Psychology) magna cum laude from the university of Michigan, and her MD, with distinction, from the University of Michigan Medical School. She is Board Certified in pediatrics.
Professor Henri Bounameaux is director of the Division of Angiology and Haemostasis, and chairman of the Department of Medicine at the University Hospitals of Geneva. His research interests include all aspects of venous thromboembolism.
Dr. Albert Bourla is the Chief Operating Officer (COO) of Pfizer, one of the world's premier innovative biopharmaceutical companies. As COO, Bourla oversees the company's commercial, strategy, manufacturing and global product development functions. He has almost 25 years of experience with Pfizer and has held a number of senior global positions across a range of markets and disciplines. Bourla is currently a board member of the Pfizer Foundation and the Biotechnology Innovation Organization (Bio), where he serves on the Executive Committee.
Kym Boycott is a Medical Geneticist at the Children’s Hospital of Eastern Ontario (CHEO), Senior Scientist at the CHEO Research Institute, and Professor of Pediatrics at the University of Ottawa. Dr. Boycott’s research program in rare diseases bridges clinical medicine to basic research and is focused on understanding the molecular pathogenesis of these disorders, enabling the design of new therapies to ultimately benefit patients and their families. She is the principal investigator of Canada’s national genome-wide sequencing platform for rare disease, Care4Rare Canada, and of the Rare Diseases: Models & Mechanisms Network, established to catalyze connections between clinical investigators discovering new genes in patients with rare diseases and basic scientists who can analyze equivalent genes and pathways in model organisms. Dr. Boycott moves the international rare disease agenda forward through her role as the Chair of the Diagnostics Committee of the International Rare Diseases Research Consortium.
A Professor of Global Public Health at the University of Strathclyde, he holds Honorary or Visiting Professorships at Glasgow University and Yale University as well. His research interests lie in disease prevention and translational research. He is founder and President of the World Prevention Alliance, a non-governmental organization committed to prevention research and actions in lower income countries.
After studying molecular biology, virology, and cellular biology, Christian Bréchot became a full Professor of Cell Biology and Hepatology. He has been the head of the clinical department of liver diseases at the Necker-Enfants Malades Hospital, General Director of the French National Agency for biomedical research (Inserm), and Vice-president in charge of Medical and Scientific affairs of the Institut Merieux.
Dr. Mark Britnell has dedicated his entire professional life to healthcare and has led organisations at local, regional, national and global levels – provider and payer, public and private. Over the past 9 years, he has worked in 77 countries on ca. 300 occasions. He was previously Chief Executive of University Hospitals Birmingham and went on to run the NHS region from Oxford to the Isle of Wight before joining the NHS Management Board as a Director-General at the Department of Health. Between 2014 and 2018, he sat on the Global Agenda Council on the Future of the Health Sector for the World Economic Forum. Mark is the author of In Search of the Perfect Health System, which has sold in over 109 countries. His new book is Human: Solving the Global Workforce Crisis. A former board member of Prostate Cancer UK, Mark survived prostate cancer at the age of 42 and has donated all royalties from the sale of this book to Prostate Cancer UK.
Professor Alex Brown is an Aboriginal medical doctor and researcher from the south coast of New South Wales, Australia. He studied Medicine at the University of Newcastle (NSW), an MPH at Hebrew University in Israel, and his PhD from University of Queensland in cardiovascular epidemiology. He is currently Chair in Aboriginal Health at the University of South Australia and Deputy Director and Theme Leader Aboriginal Health at the South Australian Health and Medical Research Institute. Alex has established an extensive and unique research program focused on chronic disease in vulnerable communities, with a particular focus on outlining and overcoming health disparities. He leads projects encompassing cardiometabolic epidemiology, understanding the psychosocial determinants of chronic disease, mixed methods health services research, and trials of pharmacological and non-pharmacological chronic disease interventions. In July 2012, Alex joined SAHMRI to develop and lead a state-wide Aboriginal health research program. He leads a team of 52 staff, 29 of whom are Indigenous. He was recently admitted to the Australian Academy of Health and Medical Sciences.
Dr Julie Bruneau is Professor in the Department of Family and Emergency Medicine at Université de Montréal. She is currently Head of the Primary Care Department at the Centre Hospitalier de l’Université de Montréal (CHUM). She is recognized as a leader in addiction medicine in Canada. At the CHUM, she implemented what became the largest academic mental health and addiction medicine facility in the province, where she is still practicing. Over the past 20 years, her research contributed to a better understanding of factors impeding and facilitating harm reduction efforts (such as syringe exchange and Opioid Agonist Therapy (OAT) to reduce HCV and HIV transmission and comorbidities among persons who inject drugs. She is currently the leader of the Quebec-Maritimes node of the Canadian Research Initiative on Drug Misuse, and a core-leader in the Canadian HEPC Research Network.
Dr. Brunet is the Chief Executive Officer of the Centre hospitalier de l’Université de Montréal (CHUM) and of the Centre hospitalier universitaire Sainte-Justine (CHU Sainte-Justine), a role he has occupied since September 7, 2015. From 2009 to 2015, he was the Director General of the CHU Sainte-Justine, before becoming its CEO. He is Vice-President of the Integrated University Health Network of the Université de Montréal (RUIS) and a full clinical professor at the Department of Pediatrics of the Université de Montréal. He is also a professor of resuscitation medicine in France and a professor of medicine at the University of Toronto. Dr. Fabrice Brunet studied medicine at the Faculty of Cochin Port-Royal, University of Paris V. He later specialized in cardiology, medical resuscitation and emergency medicine. He has also occupied several roles in the medical field across Europe and America, with a particular focus on research and teaching. Early in his career, he attended the École Supérieure de Commerce de Paris (ESCP), where he completed his medical education by studying management in a healthcare context, and eventually became a professor of hospital management. Dr. Brunet completed his management studies at Harvard University and at the University of Toronto and became a professor of healthcare at the HEC Montréal. Before he started working at the CHU Sainte-Justine, he was Director of the Department of Resuscitation and Intensive Care at the St. Michael's Hospital in Toronto and Medical Director of its telemedicine program.The experience that Dr. Brunet has garnered over the course of his career will be used to continuously improve the care that is provided to the residents of the CHUM and CHU Sainte-Justine and to respond to their needs, from birth until death.
In the European Commission since 1983, Anne Bucher is Director-General of DG SANTE since October 2018. Prior to that she was Director-General and Chair of the Regulatory Scrutiny Board as of March 2016. She also was Director for structural reforms and competitiveness in the Directorate General for economic and financial affairs from March 2011 until February 2016. Trained as an economist and statistician in Paris (PHD in macroeconomics - Ecole des Hautes Etudes and master degree from Ecole Nationale de Statistique et d'Administration Economique), Anne Bucher has worked in various fields of European policies: macroeconomic forecast and models, structural funds, evaluation of employment policies, enlargement, development aid, information society strategy and economic analysis of EU tax policy. She has held various management positions, including administrative management positions for HR and budget management.
Professor Gilbert Burnham is a physician trained in Internal Medicine with and MSc and PhD from the London School of Hygiene and Tropical Medicine. He has the experience of working in Africa before joining the Johns Hopkins Bloomberg School of Public Health. He is a professor of international health and founder of the Johns Hopkins Center for Humanitarian Health. He has extensive work with the public health needs of populations in Africa and Middle East and has worked with migrants from North Korea.
Medical doctor and Master in Social Medicine. Full professor of the National School of Public Health and Director of the Centre for Global Health at the Oswaldo Cruz Foundation, Brazil. Doctor Honoris Causa of the University NOVA de Lisboa, Portgal and Member of the National Academies of Medicine of Brazil, Portugal and Argentina. Paulo is author of more than 50 chapters of books and 170 papers. Main author of the book ‘Diplomacia da Saúde e Saúde Global: Perspectivas latino-americanas’ (Health diplomacy and global health: Latin-American perspectives).
Reinhard Busse is Professor of Healthcare Management at Technische Universität Berlin. He is also Co-Director of the European Observatory on Health Systems and Policies and a faculty member at Charité - Universitätsmedizin Berlin. His research focuses on health systems, particularly comparatively in Europe, looking at the conflicting priorities of the market and regulation as well as at performance assessment. His research also examines compensation mechanisms, integrated care, and the role of caregivers, as well as health economics and health technology assessment (HTA).
Agnès Buzyn is Professor of Hematology at the University Pierre-and-Marie-Curie in Paris. She spent a large part of her career as an academic hematologist and clinician at the University Paris Descartes - Necker Hospital, where from 1992 to 2011 she headed the adult hematology intensive care and bone marrow transplants unit. From 2002 to 2006, Professor Buzyn was the Director of a research team on tumor immunology at the National Institute of Health and Medical Research (INSERM). Her research activities have focused on bone marrow transplants, and leukemias (ALL,CML).
A. Buzyn has served as board member of a number of national organizations: the Biomedicine Agency (ABM), the Blood Institute (EFS), the bone marrow transplant and cell therapy society (SFGM-TC). From 2008 to 2013, she served as Chair of the Board of the Radioprotection and Nuclear Safety Institute (IRSN). A. Buzyn was President of the French National Cancer Institute (INCa) from May 2011 until February 2016. She has been appointed Chairwoman of the French National Authority for Health (HAS – Haute Autorité de santé) on 7 March 2016.
Winnie Byanyima assumed her functions as Executive Director of UNAIDS since 2019.
Prior to that, she has been the Executive Director of Oxfam International and served as the Director of Gender and Development at the United Nations Development Programme.
Ms Byanyima began her career as a champion of marginalized communities and women 30 years ago as a member of parliament in the National Assembly of Uganda. In 2004, she became the Director of Women and Development at the African Union Commission, working on the Protocol on the Rights of Women in Africa, an international human rights instrument that became an important tool for reducing the disproportionate effect of HIV on the lives of women in Africa.
She holds an advanced degree in mechanical engineering (in energy conservation and the environment) from the Cranfield Institute of Technology and an undergraduate degree in aeronautical engineering from the University of Manchester.
Dr Joseph Waogodo CABORE is the Director for Programme Management at the WHO Regional Office for Africa in February 2015. He oversees all technical programmes as well as the work on the SDGs and the work with the Governing Bodies in the WHO African Region. He joined WHO in 2000 and has since then served in senior positions as Inter-country Polio and Immunization Adviser for Central African countries, WHO Country Representative to Burundi and WHO Country Representative to the DRC
Graduated in Economics.Master in International Cooperation and Development. Consultant on European Affairs-Portuguese Parliament (1997-2002), Head of Office for State Secretary of Foreign Affairs and Cooperation, Deputy Secretary of State for Reg. Develop. (2004). Manager of Operational Health Program (2004-05). Managed Gulb. Advanced Healthcare Training Programs (2008-09).Currently Director Gulb. Program Partnerships for Development.Member Steering Commitee of GPEDC
He has a PhD in Health Administration, a Master in Public Health and Health Service Administration and graduated in Medicine. A specialist for Public Health, he is Professor at the National School of Public Health, at Universidade Nova de Lisboa, and taught and coordinated several university institutions in management and health administration. He was Senior Manager in health institutions such as Hospital de Santa Maria, Hospital Pulido Valente, Centro Hospitalar Lisboa Norte, Hospital de Cascais, SAMS Prestação Integrada de Cuidados de Saúde.
Carolyn Canfield works across Canada and internationally as a citizen-patient to transform healthcare culture for better patient outcomes and worker satisfaction. Her passion is for expanding opportunities for patients and families to partner with healthcare professionals in every aspect of care: practice improvement, service design, policy, evaluation, training and research. Frequent roles include keynote speaker, course instructor, seminar leader, patient engagement coach and strategic advisor. At the University of British Columbia, Carolyn is teaching undergraduate medical and nursing students, clinician-researchers and graduate students. Her energetic full-time commitment to better healthcare arises from premature widowhood in 2008 following preventable harm, unacknowledged as a system failure and ignored for organizational learning. Carolyn holds the position of honorary lecturer in the Faculty of Medicine at the University of British Columbia. In 2014 she was honoured as Canada’s first individual Patient Safety Champion by Accreditation Canada and the Canadian Patient Safety Institute.
Ben Canny is Head of the School of Medicine at the University of Tasmania, where he has responsibility for Medicine, Pharmacy and Paramedicine. Prior to this he was the convenor of the Medical Degree at Monash University. Ben has always had a vital interest in Medical Education and Medical Science, and has led the Medical Education initiative of the M8 Alliance. At present, he is leading the development of a harmonized curriculum of Global Health Education for Health Professionals to be shared by members of the M8 Alliance. He is also Vice-President of the Australian and New Zealand Associate for Health Professional Educators.
Professor Cao Xuetao major interests are immunobiology of APCs (dendritic cells, macrophages), TLR signaling and immune regulation, cancer immunotherapy and gene therapy. In recent years he is investigating the mechanisms for immune recognition and TLR signaling.
Full professor of Biochemistry at University of Foggia – School of Medicine Department of Clinical and Experimental Medicine – Laboratory of Medical Chemistry and Biochemistry. Research Activities and Interests: Molecular mechanisms of energy transduction of the respiratory chain complexes; Oxidative metabolism and redox signalling; and Physio-pathology of mitochondrial cellular bioenergetics in the contest of stem cell biology, cancer development, immune response, viral infection and circadian rhythms.
President of the National Publich Health Institute, Guine-Bissau. Member of the IHMT Consultative Board and of the CHAMPS Global Partner Board. Former positions: Director General of the West African Health Organization, CCM Permanent Secretary at Global Fund, Director General of Public Health, Member of the National Medical Commission, Physician in charge of Adults Meningitis cases during Epidemics, Physician and Director in the Bandim Health Centre, Public Health Regional Director of Cacheu. National health public studies on educating pairs, reproductive health and health services financing.
Doctor. Anesthesiologist. Intensive Care specialist. Humanitarian Missions: Mozambique, RDCongo, Pakistan, Afeghanistan, Syria, Central African Republic, Iraq. Author of the Book: 1001 Letters to Mosul.
Dentist, licensed by Dentistry Faculty of Lisbon University. Full Professor of Operative Dentistry, Faculty of Medicine, University of Coimbra, Portugal. Operative Dentistry and Aesthetics Post-Graduate Course Coordinator. Researcher at the Biomedical Institute of Light and Image, IBILI, FMUC. Member of Faculty of Medicine Scientific Council, University of Coimbra, Portugal. Member of Dental Association Directive Council.
Timothy Caulfield is a Canada Research Chair in Health Law and Policy, a Professor in the Faculty of Law and the School of Public Health at the University of Alberta and Research Director of the Health Law Institute at the University of Alberta. Over the past several years he has been involved in a variety of interdisciplinary research endeavours that have allowed him to publish over 300 academic articles. He is a Fellow of the Trudeau Foundation and the Principal Investigator for a number of large interdisciplinary projects that explore the ethical, legal and health policy issues associated with a range of topics, including stem cell research, genetics, patient safety, the prevention of chronic disease, obesity policy, the commercialization of research, complementary and alternative medicine and access to health care. Professor Caulfield is and has been involved with a number of national and international policy and research ethics committees. He has won numerous academic awards and is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences. He writes frequently for the popular press and is the author of two recent national bestsellers: The Cure for Everything: Untangling the Twisted Messages about Health, Fitness and Happiness (Penguin 2012) and Is Gwyneth Paltrow Wrong About Everything?: When Celebrity Culture and Science Clash (Penguin 2015).
Basile Chaix, as a social epidemiologist, seeks to understand how the multiple environments visited during daily life activities and related transport mode use influence health status. He was promoted as a Research Director in 2013 at Inserm. He is the coordinator of the Nemesis research team. He is the principal investigator of the RECORD Cohort Study. The RECORD GPS and MultiSensor studies have developed a tracking methodology combining GPS receivers (and other sensors) with an electronic mobility survey. For the next years, the team will focus on the MobiliSense project (European Research Council), a cohort of 1000 participants intensively monitored with sensors and smartphones, to explore the short-term and longer-term effects of air pollution and noise related to personal transport behavior on cardiovascular and respiratory health. Basile Chaix is part of the editorial board of Epidemiology, Social Science and Medicine, and Health & Place.
Dr Chammas concluded his studies in Medicine (1988) and got his PhD degree in Biochemistry (1993) at São Paulo University, while working at the Ludwig Institute for Cancer Research (1989-1993). He specialized in Glycobiology at University of California, San Diego (1994-1997). Chammas is currently Full Professor of Oncology at USP Medical School where he has been working since 2000. His major interests are in the area of Cancer Biology (Biochemistry and Cancer Cell Biology), focusing on tumor progression, carbohydrate-dependent tumor markers and tumor microenvironment, as targets for combination therapy and molecular diagnostics through imaging in cancers.
Parallel to his current position as Associate Dean, Chang-Chuan Chan is also joint-appointed Investigator of the Division of Environmental Health and Occupational Medicine, National Health Research Institutes. He is a known expert for topics like air pollution, epidemiological studies on industrial pollution and global health research.
Dr Margaret Chan was the Director-General of World Health Organisation (WHO) from 2007 to 2017. Dr Chan joined WHO as Director of the Department for Protection of the Human Environment in 2003. She was elected Director-General in 2006 and was appointed for a second five-year term in 2012.
A renowned microbiologist, geneticist and biochemist, Emmanuelle Charpentier is a Director and head of the "Regulation in Infection Biology” department at the Max Planck Institute for Infection Biology in Berlin. In addition, she holds positions as a Scientific Member of the Max Planck Society, Honorary Professor at Humboldt University and Alexander von Humboldt Professor, Germany, and Visiting Professor at Umeå University, Sweden. She is recognised for her key pioneer contribution to the development of the widely acclaimed genome editing technology CRISPR-Cas9.
Dr. Omar Cherkaoui is a junior doctor freshly graduated from the University of Rabat, Morocco. He is the President of the International Federation of Medical Students' Associations (IFMSA), one of the world’s oldest and largest student-run organizations, that represents, connects and engages every day with medical students from 122 countries. Dr. Omar Cherkaoui is a strong advocate of health for all, and draws his passion from the work the Federation is doing globally to educate and build capacity of future health professionals on various global health topics. Prior to being President, he was Director of the IFMSA Professional Exchange Program, that gives the opportunity every year to over 14.000 medical students from around the world to go abroad, allowing them to experience different health systems. He also served the IFMSA as New Technologies Director, and advocated for the importance of technology and telemedicine for medical students.
Swara Bhaskar Chitrapu works in the Hindi film industry and is best known for mainstream productions and starring roles in independent films. In 2017, she openly addressed the depiction of women in the Indian movie industry and became a leading voice on the topic of women’s empowerment. She holds a bachelor's degree in English literature and a master's in Sociology.
Connie Clement is the Scientific Director of the National Collaborating Centre for Determinants of Health, located at St Francis Xavier University in Antigonish, NS. Prior to joining the NCCDH Connie has held positions as Director of Planning and Policy at Toronto Public Health, along with other management and front line positions. She is past Executive Director of Health Nexus/Nexus Santé, a key Ontario-based health promotion resource organization, and of Social Venture Partners Toronto, a venture philanthropy collaborative. In 2014, Connie was awarded the Canadian Public Health Association’s certificate of merit. She has a long history as a volunteer, is a proud mother and loves living on salt water.
Doctor Éric A. Cohen is Director of the Laboratory of Human Retrovirology at the Institut de recherches cliniques de Montréal (IRCM). He is also Professor of Virology at the Department of Microbiology, Infectiology and Immunology at the Université de Montréal and recipient of the IRCM-Université de Montréal Chair of Excellence in HIV Research. Dr. Cohen’s research aim to better understand HIV-host interactions regulating viral replication, transmission, and persistence. His studies on the interactions between HIV and antiviral effectors of the host innate immune response have fostered a transforming understanding of HIV persistence and opened new avenues for the development of HIV curative strategies. Dr. Cohen is a fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences and a member of the editorial board of Retrovirology. Since 2014, he leads the Canadian HIV Cure Enterprise (www.cancurehiv.org), a pan-Canadian multidisciplinary research consortium dedicated to HIV cure research.
Educated in Istanbul University Medical School, he is a specialist for internal medicine and the research on allergies.
For 24 years Cole worked as a researcher and also held various research management positions at the Institut Pasteur. He was Director of Strategic Technologies and then Executive Scientific Director, contributing to several patent applications relating to HIV/AIDS, cervical cancer and multidrug-resistant tuberculosis. He participated in the Scientific Advisory Boards of the Institut Pasteur in Iran, the Institut Pasteur in Montevideo and the Institut Pasteur in Lille. Professor Cole was also acting President of the Institut Pasteur in Paris in 2005. He has been the recipient of many national and international prizes and distinctions. In 2009, he was awarded the World Health Organization’s prestigious Stop-TB Partnership Kochon Prize for his leadership and groundbreaking accomplishments in genetic research on M. tuberculosis and his contribution to novel therapeutic strategies for tackling TB. Stewart Cole has also published more than 350 scientific papers on infectious diseases, most notably tuberculosis and leprosy.
Previously a Senior Health Policy Analyst in the Health Division, she is now responsible for OECD work on health which aims at providing internationally comparable data on health systems and applying economic analysis to health policies, in this way advising policy makers, stakeholders and citizens on how to respond to healthcare demands.
Wilson M. Compton, M.D., M.P.E. is Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health. NIDA supports most of the world’s research on health aspects of drug abuse and addiction related to preventing drug abuse, treating addiction and addressing serious health consequences of drug abuse, including related HIV/AIDS and other conditions. Dr. Compton received his undergraduate education at Amherst College and his medical education at Washington University in St. Louis. Over his 25 year career, Dr. Compton has achieved multiple scientific accomplishments. He is author of more than 150 articles; is an invited speaker at multiple high-impact venues, and has received multiple awards. Of note, Dr. Compton received the Health and Human Services Secretary’s Awards for Meritorious Service in 2013 and Distinguished Service in 2014.
H. Cormier, prof, Faculté de médecine, U de Montréal, founder PRÉSENCE Mindfulness Montréal Ctr. PRÉSENCE 8 pilars of health: Resilience; Ecology; Spirituality; Exercice, physical & mindful; Nutrition; Connectedness; Engagement. The goal is to promote student and medical School community Well-Being. MD with a specialty in psychiatry, a Harvard Master of Public Health, a Strasbourg diploma médecine méditation neurosciences, Oxford mindful + Hopkins Intl Health training.
Ana Correia has a degree and a master in International Relations having taught in the area of cooperation. Throughout her career she has been involved in multilateral and bilateral cooperation and development issues. From 2006 to 2008 she was coordinator of Cooperation projects at the Portuguese Embassy in Bissau. She has actively participated in the organization of several international seminars on the subject. Since 2014 she is Head of Division of Cooperation at Directorate-General of Health.
Thomas B. Cueni is Director General of IFPMA since 1 February 2017. Prior to joining IFPMA he was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland. For many years Thomas Cueni has been involved in the work of the European Federation of Pharmaceutical Industries and Associations, EFPIA, where he most recently served as Vice-Chair of
the European Markets Committee and association representative on the Board. He represented the industry on the EU High Level Pharmaceutical Forum, was Chairman of EFPIA’s Economic and Social Policy Committee and Chairman of the EFPIA Task Force on the EU Commission’s Pharmaceutical Sector Inquiry. Thomas Cueni also represented Interpharma, which he successfully transformed from the association of Swiss Rx companies to the association of pharmaceutical research companies in Switzerland, on the Council of IFPMA. Prior to his appointment with Interpharma, Thomas Cueni had a career as a journalist.
Ashlee Cunsolo is a passionate researcher and environmental advocate, working with research and policy to make a difference in how we live with and in this world. As a community-engaged social science and health researcher working at the intersection of place, culture, health, and environment, she has a particular interest in the social, environmental, and cultural determinants of Indigenous health, intercultural learning and dialogue, environmental ethics, and the social justice implications of social, environmental, and health inequality. For the past 10 years, she has been working in partnership with Inuit across Canada examining the ways in which climate change is impacting health and wellness. She is a former Tier II Canada Research Chair and Associate Professor, is a member of the Royal Society of Canada’s College of New Scholars, Artists, and Scientists, and is one of Nature Canada’s 75 Women for Nature. She is currently the Director of the Labrador Institute in Happy Valley-Goose Bay.
After earning his BA in political science from the University of Geneva, Yves Daccord began working as a TV journalist and producer at Télévision Suisse Romande in Geneva. He joined the ICRC in 1992 and became deputy head of its Division for the Promotion of International Humanitarian Law in 1997. In 1998, he took on duties at the helm of its Communication Division. In 2002, Daccord was named Director of Communication, and was selected as ICRC Director-General in 2010.
Working for the NCD Alliance since its founding in 2009, Katie Dain holds experience in organizational and strategic development, global advocacy and policy-making, program design as well as capacity-building in low- and middle-income countries. Before joining the NCD Alliance, she worked at the International Diabetes Federation in Brussels, leading their global advocacy program and establishing the first Women and Diabetes program.
A biochemist and structural biologist trained in basic sciences, his research activities have focused on different topics such as molecular virology, biochemistry, molecular biology, nuclear magnetic resonance, microbiology, structural biology, and bioinformatics. He has chaired numerous grant committees and has sat at councils including the Fondation pour la Recherche Médicale, European Molecular Biology Laboratory and Ecole Normale Supérieure Biology Dpt.
Steve Davis, president and CEO of PATH, combines extensive experience as a technology business leader, global health advocate, and social innovator to accelerate great ideas and bring lifesaving solutions to scale. Over his career he has worked extensively on refugee programs and policies and Chinese politics and law. Davis is currently a lecturer on social innovation at the Stanford Graduate School of Business. He is also a member of the Council on Foreign Relations and sits on several advisory groups, including as a trustee of the World Economic Forum’s Global Health Challenge.
President of the National Health Institute Dr. Ricardo Jorge (INSA) - State Laboratory in the Health Sector, National Reference Laboratory and National Health Observatory of Portugal. Past roles include the Vice Presidency of the Regional Health Administration for the Center of Portugal, the Presidency of the Board in the Psychiatric Hospital Center of Coimbra, and member of the National Commission for AIDS Eradication's Consultee Board. Graduated in Medicine and postgraduated in Public Health at Nova Medical School, Lisbon.
Sociologist, co-founder of the Center for Social Studies Amílcar Cabral-CESAC. Member of the Council for the Development of Research in Social Sciences in Africa-CODESRIA, researcher at the Center for International Studies of the University Institute of Lisbon-CEI/IUL-ISCTE and the Center for International Studies Border Epistemology and Psycho-Political, Economy and Culture, Universide La Frontera, member of the leadership of the Guiean Civil Society Network for Food and Nutrition Security.
Ms. Sana de Courcellesis Executive Director of the Sciences Po School of Public Affairs and an affiliated professor in the areas of public innovation and health.Before joining Sciences Po, Sana de Courcelles served at the Assistant Director-General of the WHO Office, in charge of Health and Innovation Systems. A graduate of CELSA, Sana de Courcelles was Parliamentary Counsel for the head of a French Prime Minister Service, the General Commissioner for Investment. She was then a consultant in strategy and organization in the public sector at Capgemini Consulting
Professor Ivan Dedov is the president of the Russian Academy of Medical Sciences and a member of the Russian Academy of Sciences. He devoted much time to fundamental and applied problems of endocrinology and is one of eminent organizers in medical science in Russia.
Responsible for running the global Healthcare Center of Excellence and accelerating growth through strategic partnerships, co-innovation efforts, and aligning SAP solutions with market needs, he has focused his career on driving value at the intersection of clinical, business and technology. Before joining SAP, he was Chief Medical Officer at MedAptus, a privately held, leading provider of revenue cycle management solutions to academic medical centers.
In 2013, Manuel Delgado was designated by The Ministry of Health as board member of the Council for The Hospital Reform. He was President and Chief Executive Officer of the Board of Curry Cabral Hospital, a central and general Hospital in Lisbon, Portugal, from 2007 to 2010.
Dr. Roopa Dhatt is a physician by training and an advocate by principle, striving for greater health and well-being for all people through working in global health. She is the Executive Director and co-founder of Women in Global Health, a movement that strives to bring greater gender equality to global health leadership. Since its foundation Women in Global Health, an organization staffed entirely by volunteers, has expanded to become a global movement, with chapters in four continents and more than 21,000 followers in 90+ countries.
Manfred Dietel has headed the Institute for Anatomic Pathology at the Christian Albrecht University in Kiel since 1989. In 1993, he became Director of the Institute for Anatomic Pathology at the Charité, Humboldt-University in Berlin, and was Dean of its medical faculty from 1997-1999. From 2001-2004 he spent a stint as the Charité’s Medical Director and Managing Director.
Peter E. Dieter, Ph. D., est professeur de biochimie médicale à la Faculté de médecine Carl Gustav Carus de la Technische Universaität à Dresde, en Allemagne. Il a été un des premiers en Allemagne à réformer les vieux programmes de médecine (dont celui de Dresde) au profit d’un programme interdisciplinaire moderne, intégratif et basé sur l’apprentissage par problème. Peter Dieter est membre de nombreuses organisations allemandes et internationales impliquées dans l’éducation médicale, les programmes d’assurance de la qualité et l’accréditation. Il a eu un rôle à jouer dans l’accréditation et l’évaluation des programmes de médecine de nombreuses écoles de médecine en Allemagne, en Europe et en Asie, un rôle qu’il défend encore aujourd’hui. Il est également président de la Association of Medical Schools in WHO Europe (AMSE), à Berlin. En tant que tel, il tente de mettre en place une procédure d’assurance de la qualité (accréditation) uniforme en Europe qui serait reconnue par tous les pays, parce que basée sur les normes des programmes de premier cycle de la Fédération mondiale pour l’éducation médicale.
Prof. Peter E. Dieter, PhD is a senior professor ay Faculty of Medicine at TU Dresden (FMTUD) in Germany and the president of AMSE. He has been FMTUD Representative for International Relations, Professor of Biochemistry at FMTUD, Dean of Medical Education and Student Affairs at FMTUD, and fellow at the National Institute of Mental Health, Bethesda in USA
He took office in July 2013 as incumbent Mayor of Addis Ababa, capital and largest city of Ethiopia. Prior to this, he served as Minister of Transport.
Annette Dixon is the Vice President for Human Development at the World Bank Group, overseeing the Global Practices for education; health, nutrition, and population; gender; and social protection and jobs. She was previously the Bank’s Vice President for the South Asia Region. In managing the World Bank’s engagement in South Asia to end extreme poverty and boost shared prosperity, Annette led relations with eight countries, including India—the institution’s biggest client. She also oversaw lending operations and trust-funded projects worth more than $10 billion a year. Prior to joining the World Bank, Annette Dixon worked for the Government of New Zealand as Chief Executive of the Ministry of Youth Affairs. She also served as General Manager, Sector Policy; Deputy Director-General in the Ministry of Health; Director of Health Policy, Department of the Prime Minister; and Manager Policy Division, Ministry of Women’s Affairs. Born in New Zealand, Annette holds a Master of Public Policy. She was also awarded the Harkness Fellowship in Health Policy and Management at the George Washington University in 1994-1995.
Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Australia, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years. He has developed extensive national and international collaborations, and is internationally recognized in the areas of natural history of acute and chronic HCV infection, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs. He holds large-scale ongoing public sector research funding from U.S. National Institutes for Health, and Australian National Health and Medical Research Council (NHMRC). Professor Dore has been President of the Australasian Society for HIV Medicine (ASHM), a member of NHMRC Council, and currently is a NHMRC Practitioner Fellow.
She held the Swiss Federal Department of Home Affairs, was the first woman ever to be elected President of the Confederation and won several referendums, including a revision of the Health Insurance Bill, the 10th revision of the social security system, and a drug policy based on prevention, therapy, help and rehabilitation. She is a member of the Council of Women World Leaders.
Christian Drosten is the Director of the Institute of Virology of the Charité - Universitätsmedizin Berlin. This year he has become an internationally respected COVID-19 expert. In 2003 he discovered the unknown virus causing SARS and developed a diagnostic test that enabled public health authorities worldwide to stop a beginning pandemic. Drosten has co-authored more than 300 peer-reviewed papers and coordinated research consortia funded by the European Union, Deutsche Forschungsgemeinschaft, and the German Ministry of Research. He is a member of the internal advisory board of the German Center for Infection Research (DZIF) and the speaker of the German National Research Network for Zoonotic Infections. He received the German Federal Cross of Merit for his work to counter the SARS epidemic.
Mr. Vincent Dumez holds a finance degree and a master in science of management from Montreal’s international business school Hautes Études Commerciales (HEC). Up until 2010, Mr. Dumez was an associate in one of Montreal’s most influential consulting firm where he acted as a senior strategic consultant. Suffering from severe chronic diseases for more than three decades, M. Dumez has been actively involved in the promotion of the ‘patient partner’ concept at Montreal University. This involvement has come forward over the recent years through the completion of his masters dissertation on patient-doctor relationship, his contribution to the training of patients, his work on boards of healthcare organizations and his involvement as a speaker in healthcare conferences. Since 2010, Mr. Dumez has developed the patient partnership program at the Faculty of Medicine. He’ now co-leading with Dr Antoine Boivin the Centre of Excellence on Partnership with the patients and Public.
A founding member and member of the Executive Committee of the Academy at Harvard Medical School, Victor Dzau is a leader in cardiovascular translational research. He heads his laboratory in the study of molecular and genetic mechanisms of cardiovascular disease, and has applied genomic and gene transfer technologies to develop novel therapeutic approaches.
Aled Edwards is CEO of the Structural Genomics Consortium (SGC), a public-private partnership that generates open-access research tools to support drug discovery.
Over the years, the SGC has contributed the 3D structures of >2,000 different human proteins into the Protein Data Bank – corresponding to ~15% of the available structural information for the human proteome. Some of these proteins have been used as templates to generate small molecule inhibitors. All reagents derived from the SGC are made available to the community without restriction on use. Some of chemical reagents identified new targets for cancer drug discovery. Their relevance is now being tested in clinical trials. Al trained at McGill and Stanford, held a faculty position at McMaster and is currently on faculty at the Universities of Toronto and Oxford.
Austrian astrophysicist Pascale Ehrenfreund has held professorships at the University of Amsterdam, the University of Leiden, the Jet Propulsion Laboratory in Pasadena and the Elliott School of International Affairs (George Washington University). She’s Lead Investigator at the NASA Astrobiology Institute and was President of the Austrian Science Fund (FWF) from 2013-2015.
He worked in economic development and governance for several decades and founded Transparency International in 1993. Until 2011, he was the founding Chairman of the Extractive Industries Transparency Initiative. He is Honorary Professor at the Freie Universität Berlin. His academic career included teaching positions at the University of Frankfurt am Main, Harvard Kennedy School, Johns Hopkins School of Advanced International Studies and Georgetown University.
Professor Karl Max Einhäupl is a trained Neurologist. In 2004, he was awarded the German Federal Cross of Merit. From 1993-2008 Director of the Clinic for Neurology, Charité - Universitätsmedizin Berlin and from 2007 to 2008 Head of the Centre “CC15: Neurology, Neurosurgery and Psychiatry”. Since 2008, he is Chief Executive Officer of the Charité - Universitätsmedizin Berlin.
PhD in Biochemistry with specialty in Microbiology from the University of Coimbra (UC). Postdoctoral studies on the biosynthesis of vital mycobacterial polysaccharides in a quest for new targets for innovative TB therapies. Currently a Group Leader at CNC-UC as head of Molecular Mycobacteriology & Microbiome research. His Group’s growing collection of mycobacteria and other pathogens from hospitals, home water of infected patients and from diabetics foster genomic and epidemiological studies for therapeutic and public health policy advice. His most recent project deals with the imminent co-pandemic TB-diabetes.
Erika Placella has over 18 years of experience in public health. She is currently the health advisor for the Swiss Agency for Development and Cooperation (SDC) for Eastern Europe and Central Asia and the focal point for Non-Communicable Diseases (NCDs) within the SDC’s Global Programme Health Division. Ms. Placella has previously worked for various medical and public health organisations in Africa, Asia and the Middle East in the field of zoonoses, sexual, reproductive, child health, food security, and NCDs. She is a member of the WHO Global Coordination Mechanism on NCDs working groups and collaborates closely with the WHO Regional Office for Europe on supporting member states in developing, monitoring, steering and evaluating NCD strategies and action plans.
Dr. Carissa F. Etienne has served as Director of the Pan American Health Organization since 2013. She was previously Assistant Director-General for Health Systems and Services at the World Health Organization in Geneva, Switzerland. During her tenures at WHO and PAHO, Dr. Etienne led the efforts to renew primary health care and to strengthen health systems based on primary health care, promoting integration and improved functioning of health systems. She has also spearheaded policy directions for reducing health inequalities and advancing health for all through universal coverage, people-centered care, the integration of health into broader public policies, and inclusive and participatory health leadership.
Amílcar Falcão was previously Director of the Faculty of Pharmacy (2010-2012) and the Interdisciplinary Research Institute (2013-2019). He was also Vice Rector of the University of Coimbra (2011-2019). He is the author of more than 230 articles in scientific journals. He was directly involved in the development of the first Portuguese medicine (Eslicarbazepine Acetate - Zebinix®) as a consultant for BIAL Laboratories.
Jeremy Farrar is Director of the Wellcome Trust, a global charitable foundation (both politically and financially independent) which exists to improve health for everyone by helping great ideas to thrive. Jeremy is a clinician scientist who before joining Wellcome was, for eighteen years, Director of the Clinical Research Unit in Viet Nam, where his research interests were in infectious diseases, tropical health and emerging infections. He has contributed to almost 600 peer-reviewed scientific papers and served on several global advisory committees. In 2015 he was recognised by Fortune magazine as 12th in the top 50 of the World’s Greatest Leaders.
Before joining the IRCM, Dr. Fehlmann was President and CEO of the Cancer Research Society. Previously, he was also Founding President and Chief Executive Officer of the NEOMED Institute as well as founding President and CEO of CQDM, a pre-competitive research consortium based in Montreal. He is the principal author of more than 100 scientific publications. Dr. Fehlmann is the founder of Aster Biotechnologies in France, where he was the President and CEO, as well as the President and CEO of Chronogen in Montreal.
Actively involved in basic, translational and clinical HIV research efforts for more than 30 years, Mark Feinberg has held numerous leadership positions in academia, government and industry, championing successful approaches for product development and delivery and forging impactful multi-sector partnerships.
Was born in Lisboa in 1962, has obtained a PhD and “habilitation” in Mechanical Engineering at IST in 1993 and 2004, respectively. He was the National Director of the MIT-Portugal Program in the field of Engineering Systems, and was is also the coordinator of the Sustainable Energy Systems PhD program at IST. He is since 2016 the President of the Fundação para a Ciência e a Tecnologia (FCT), the Portuguese funding agency for science, technology and innovation.
Director of the Geneva Office of UNFPA. Secretary of State for National Defence in the XX Constitutional Government of Portugal; Chair of the All Party Group on Population and Development; Former Vice President of the Executive Committee of the European Parliamentary Forum. Lecturer at ISCSP - University of Lisbon. Associate Researcher at the Centre Interdisciplinary for Gender Studies. Monica has several articles and book chapters published on cooperation, human rights and gender equality, and books published on the United Nations System.
Dr Tarcisio is currently Dean of the Faculty of Medicine of the University of São Paulo and full professor at the Department of Orthopedics and Traumatology since 2003. Head of the Discipline of Spinal Disorders, his major interests are Spinal Cord Trauma and Degenerative Spinal Lesions. He has been developing several research projects within his area of activity, focusing on the protocols of Stem Cells for Spinal Cord Injury.
Oran began obtained a Master’s degree in Forensic Anthropology, from the University of Bradford, and in Human Rights and Political Theory at the University of Essex. Oran worked as a forensic anthropologist with the United Nations in Former Yugoslavia, Kosovo and Cyprus. He worke as Regional Forensic Advisor for the Western Balkans (2008-11), Forensic Advisor for Iraq (2012-13), where he was based in Amman and Baghdad, and most recently served as Deputy Head of Forensics for the ICRC (2013-17).
HealthCare Director at Glintt. eHealth expert at the European Commission. Advisory Board member of European Projects. Former positions: Business Creation coordinator deputy within InnoLife – European Institute of Innovation and Technology Health; IS/IT B2B product management director and Head of Health, Education and Financial services at Portugal Telecom. PhD in Bio/Nanotechnology with the development of electronic DNA chips for SNP detection, Electronically addressed DNA chips with optoelectronic detection.
Dr. Maria Flachsbarth joined the Christian Democratic Union of Germany (CDU) in 1991. She became a member of the German Parliament in 2002. Since 2006, she has been deputy chair of the CDU in the state of Lower Saxony, and since 2007, she has chaired the CDU district association for Hanover. From 2002 to 2013, she served on the Parliamentary Committee on the Environment, Nature Conservation and Nuclear Safety. From 2009 to 2013, she chaired a Parliamentary Committee of Inquiry on the envisaged radioactive waste disposal facility at Gorleben, and she was the special representative for churches and religious communities of the CDU/CSU parliamentary group. Then from the end of 2013 to March 2018, she served as Parliamentary State Secretary to the Federal Minister of Food and Agriculture. Since March 2018, she has been Parliamentary State Secretary to the Federal Minister for Economic Cooperation and Development.
A professor of Public Health at University Descartes, Sorbonne Paris Cité, he is chair of the Centre Virchow Villermé de Santé Publique Paris-Berlin, co-chairs the European Academic Global Health Alliance, is president of the European Agency for Public Health Education Accreditation and Founding Director of the Institute of Global Health, University of Geneva. In 2016, Antoine Flahault was the International President of the World Health Summit.
Henrietta H. Fore has been UNICEF’s Executive Director since 2018. She has worked to champion economic development, education, health, humanitarian assistance and disaster relief in a public service, private sector and non-profit leadership career that spans more than four decades. She has previously served as Administrator for USAID and Director of United States Foreign Assistance, Undersecretary of State for Management at the US Department of State, Director of the United States Mint in the US Department of Treasury, and Chair of the Board and Chief Executive Officer of Holsman International, a manufacturing and investment company.
Medical Doctor, Specialist in Public Health, Specialist in Malaria, Master in Public Health, PhD in Biomedicine Sciences, Medical Parasitology. Former National Director of Endemic Diseases (Angola), Former General Secretary of The International Federation of Tropical Diseases, Coordinator of the 1st Edition of PHD-Biomedical Sciences Course in Angola, Member of Some World Tropical Medicine Association PUBLICATIONS in different infectious diseases.
Pierre Fournier studied in medicine (Nice, France), in biostatistics (Paris VI, France), in tropical medicine (Aix-Marseille, France) and in public health (Montréal, Canada).
Before joining the Université de Montréal in 1986, he worked at the African Development Bank (Abidjan, Côte d’Ivoire), at the Faculty of Medicine of the University of Nice (France) and in Burkina Faso as Deputy Regional Health Officer.
He works in the areas of maternal health, health systems analysis, program evaluation and human resources development, in various countries: developed (Canada, Europe), transitional (Central Europe and Balkans) and developing (Africa, Latin America).
He is a Professor (Department of Social and Preventive Medicine), and a Researcher of the Global Health Research Group (Research Center of the University of Montreal Hospital). He was director of the Leadership program in population and health (funded by the Bill and Melinda Gates Foundation) and a consultant for the major national and international health organizations (WHO, UNFPA, UNICEF, IDRC, CIDA).
He was the founding director of the International Health Unit (1989-1996) and Director of the Department of Social and Preventive Medicine, Faculty of Medicine (1996-2002). He was appointed in 2013 as the first Dean of the School of Public Health at the Université de Montréal.
With an impressive track record as a business executive - most recently as CEO of Lufthansa - and an exceptional global network, he has been a member of the Roche board since 2011 and was elected as Chair in 2014. He is a member of the Assembly of the International Committee of the Red Cross and Honorary Professor for Business Administration at University of St. Gallen.
Sarah Fraser is a clinical psychologist and professor at the school of Psychoeducation at Montreal University, researcher at the Institut de Recherche en Santé Publique de l’Université de Montreal. She works in the field of Aboriginal health, youth protection services and community wellbeing. Over the past years she has been working with an Inuit community in an action-research project around community mobilization for the improvement of family oriented prevention services. Inspired by systemic thinking, she has explored a variety of themes including micro-interactions within youth protection services, associations between family wellbeing and community wellbeing as well as system dynamics in institutional and community change. More specifically she is interested in the interface between community and institutions ; patients and services.
Presides the Board since 1986. Among other professional projects, he holds the most high-level management positions concerning intensive care, medical emergency and internal medicine at the Professor Doutor Fernando Fonseca Hospital, since 2000, being a member of the Clinical Management since November 2017.
Ana Teresa Freitas is CEO and co-founder/shareholder of HeartGenetics, Genetics and Biotechnology SA, since 2013. She is Full Professor at the Department of Computer Science and Engineering at Instituto Superior Técnico, University of Lisbon. She holds a PhD in Computer Engineering and a diploma from the Advanced Management Program on Innovation and Entrepreneurship. Her main expertise is on the areas of Bioinformatics, Human genetics, Health Informatics, Algorithms and Data Mining.
Twelve years as Deputy Director General of Health gave Graça Freitas tremendous experience in crisis management. Graça is Medical Doctor, always devoted to public heath. In 2017 was nominated as Director-General of Health.
Dr. Frieden is a physician trained in internal medicine, infectious diseases, public health, and epidemiology. He began his public health career in New York City confronting the largest outbreak of multi-drug resistant tuberculosis to occur in the US. He was then assigned to India, on loan from the Centers for Disease Control and Prevention, where he helped scale up a program for effective tuberculosis diagnosis, treatment, and monitoring. Asked to return to New York City to become Mayor Mike Bloomberg’s Health Commissioner, he directed efforts to reduce smoking and other leading causes of death that increased life expectancy by 3 years. As Director of the US Centers for Disease Control and Prevention, Dr. Frieden oversaw the work that helped end the 2014 West Africa Ebola epidemic. Dr. Tom Frieden now leads Resolve to Save Lives, a $225 million, 5-year initiative of Vital Strategies, which aims to save millions of lives from cardiovascular disease and make the world safer from epidemics.
Professor Gérard Friedlander focused his experimental and clinical research on the molecular basis of phosphate homeostasis in health and disease, and on the cellular mechanisms underlying the progression of renal lesions during chronic kidney disease. Special fields of his interests and expertise are the links between clinical practice, clinical investigation, experimental and translational research and medical education.
Shunichi Fukuhara received his clinical training at the University of California at San Francisco, and was board-certified in Internal Medicine. He practices cardiology in Japan. His main research interests are clinical evaluative research and health services research. In 2000, Fukuhara founded Kyoto University’s Department of Healthcare Epidemiology.
Prof. Cem Gabay is Dean of the Faculty of Medicine at University of Geneva, as well as Director of Education and Research and Head of the Division of Rheumatology at Geneva University Hospitals. He is an expert in the field of rheumatology, with research focusing on various aspects of cytokine biology of the interleukin-1 family, and clinical aspects of rheumatoid arthritis.
Dr. Luiz Augusto Galvão represents Fundação Oswaldo Cruz (FIOCRUZ). He is a medical doctor with a Master’s and a Doctorate degrees in Public Health. Dr. Galvão's professional career includes extensive teaching and research experience at FIOCRUZ and a number of technical publications. He spent 25 years at PAHO/WHO as head of sustainable development and health equity. He served as president of the Brazilian Society of Toxicology and currently is a senior researcher at FIOCRUZ´s Center for Global Health.
A specialist in pharmacology and molecular medicine, Detlev Ganten is one of the world’s top scientists in the field of hypertension. He is the Founding President of the World Health Summit, a former CEO of the Charité – Universitätsmedizin Berlin and Founding Director and CEO of the Max Delbrück Center for Molecular Medicine.
Since 2004, Laurie Garrett has been a senior fellow for global health at the Council on Foreign Relations in New York. Garrett is the only writer ever to have been awarded all three of the Big "Ps" of journalism: the Peabody, the Polk, and the Pulitzer. Her expertise includes global health systems, chronic and infectious diseases, and bioterrorism.
Diane Gashumba is the Rwandan Minister of Health of the Republic of Rwanda since October 4, 2016. From March 29, 2016, she served as the Minister of Gender and Family Promotion. She is a pediatrician by profession bringing in much experience in global maternal, newborn and child health with focus to gender issues. She was Director of two district hospitals and President of the National Women Council, thus bringing in strong experience in empowering women.
Bill Gates is the principal founder of Microsoft and one of the richest and most influential people on Earth. Gates studied mathematics and computer science at Harvard in 1973 but dropped out to pursue his own coding. In 1976 Gates founded Microsoft, but it wasn’t until 1980 that the company got its big break when IBM approached them. In 1990 Microsoft released its first version of Windows and it soon became a best seller. Since 2008, Gates has focused his energy on working with his charitable foundation, “The Bill and Melinda Gates Foundation’ which he formed with his wife. His main areas of interest in philanthropy involve global issues ignored by the government. He is also interested in improving health and the environment.
After conducting research on Human Anatomy at Sapienza University from 1983 to 1986, Eugenio Gaudio began teaching at the University of L’Aquila in 1987 and served as Dean of the Faculty of Medicine and Surgery from 1997 to 2000. He returned to Sapienza as a Professor of Human Anatomy. From 2008 to 2010, he was Director of the Department of Human anatomy. Since 2010, he has been President of the Faculty of Pharmacy and Medicine and President of the Permanent Conference of Italian Faculties and Schools of Medicine and Surgery.
Lise Gauvin is a Full Professor and Vice-Dean for research at the School of Public Health at the Université de Montréal and a Researcher and Associate Scientific Director for Population Health Research at the Centre de recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM). She completed her doctoral work in physical activity sciences in 1985 at the Université de Montréal. In addition to her current academic position, she has held positions at Queen’s University in Kingston, Ontario and Concordia University in Montreal, Québec. In September 2015, she was named a Fellow of the Canadian Academy of Health Sciences. In August 2016, she was named a member of the new Institute Advisory Board on Health Promotion and Disease Prevention of the Canadian Institutes of Health Research. Her research focuses on socio-environmental and individual determinants of involvement physical activity and the reach, acceptability, and impact of interventions to promote physical and prevent eating disorders. She uses innovative data collection and analysis techniques including real-time data capture, multilevel modeling, and natural experiments to gain new insights into intervention.
François Gemenne is the executive director of the interdisciplinary research programme Politics of the Earth at Sciences Po (Médialab) in Paris. A specialist of environmental geopolitics and migration dynamics, he is also a FNRS senior research associate at the University of Liège, where he is the Director of the Hugo Observatory. He also lectures on environmental and migration policies in various universities, including Sciences Po (Paris and Grenoble) and the Free University of Brussels, where he holds the Bernheim Chair on Peace and Citizenship. His research deals mostly with environmental and migration governance. He has worked in particular with populations displaced by environmental changes, including natural disasters, and the policies of adaptation to climate change. He has been involved in a large number of international research projects on these issues, including EACH-FOR, HELIX, EDGE and MECLEP, for which he is the global research coordinator. He also coordinated the DEVAST project, one of the first international projects to examine the social and political consequences of the Fukushima disaster.
Dr. Stefan Germann is the CEO of Fondation Botnar, which works to improve the health and wellbeing of children and young people in growing secondary cities, connecting diverse partners and investing in solutions that leverage AI and digital innovation. Germann was previously Executive Director of onegoalglobal.org, an innovative collaborative child nutrition and healthy lifestyle campaign, and Senior Director of the World Vision International Sustainable Health Partnership, Innovation and Accountability unit based in Kuala Lumpur, Malaysia. He has also held several board and advisory board memberships.
Dr Abdul Ghaffar has worked for over 30 years in low- and middle-income countries managing research for health; planning, designing and evaluating national health systems; and teaching health policy and management. Before joining the Alliance in 2010, Dr Ghaffar served as Regional Advisor for Research in the Eastern Mediterranean Office of the World Health Organization. Earlier, he worked as a Health Policy and Systems Specialist at the Global Forum for Health Research. Dr Ghaffar began his career in Pakistan as a public health physician, eventually transitioning into various senior leadership positions such as Assistant Director-General of Policy and Planning; Deputy Director-General of International Health; and Director of the Health Services Academy, a national school of public health.
Ms Stefania Giannini was appointed UNESCO's Assistant Director-General for Education in May 2018, becoming the top United Nations official in the field of education. In this position, she provides strategic vision and leadership for UNESCO’s Education Sector in coordinating and monitoring the implementation of the Education 2030 Agenda, encapsulated in Sustainable Development Goal 4. She has devoted her career to promoting education as a fundamental human right, through the importance of language, lifelong learning, culture, freedom of expression and identity, in an effort to ensure more inclusive and equal societies.
Denis Gilhooly has over three decades of experience working in the field of global health and information and communication technology for development (ICT4D) in both the private sector and UN system. He is currently CEO, Global Digital He@lth 2030 Innovation Task Force & Co-Chair, Global Digital Health Initiative 2030 – multi-sector and inter-disciplinary partnerships dedicated to data-driven invention, innovation and investment for catalytic collaboration on UHC 2030 and the SDGs.
Dr. Gitahi is the Group CEO/Director-General Amref Health Africa and also Co-Chair of the UHC2030 WHO and World Bank initiative for achievement of UHC by 2030. Until his appointment at Amref Health Africa, Dr Gitahi was the Vice President and Regional Director Smile Train, a Global cleft charity. As a medical doctor, he worked both in the public and private sector. He has extensive experience working in the private sector having worked in senior executive roles at GlaxoSmithKIine and Nation Media Group.
He is also member of the Private Sector Advisory Board of Africa CDC and of the World Health Organization’s Community Health Worker Hub. He is member of the Board of Directors of The Standard Group and holds board member positions across Amref Health Africa offices in Africa.
Roland Göhde is Chairman of the Board at German Health Alliance (GHA), an initiative of BDI - Federation of German Industries, jointly established with the German government in the year 2010, and he is Senior Managing Director of the German diagnostics and biotechnology company Sysmex Partec. Before, he had the position as HIV/AIDS Project Coordinator at Partec, subsequently as Director of the Partec Essential Healthcare Division and from 2000 to 2014 as Managing Partner. Göhde is a Member of the UNAIDS Health Innovation Exchange Advisory Board, the World Health Summit Council, the Management Board of the German-African Business Association 'Afrika-Verein', the Board of the BDI Committee on the healthcare industry, and Chair of the Private Sector Advisory Board of GIZ. In addition, he is the main initiator of the 'Action Group on Ebola' and the 'German-African Healthcare Symposium' launched in 2014. Göhde has been active as Chairman of the Board of the Free State of Saxony biotechnology/life sciences association 'biosaxony' from 2009 to 2016. From 2012 to 2014 he acted as Founding Member of the Advisory Board of the Coordinating Agency for the Free State of Saxony Healthcare Sector. Roland Göhde is Co-Founder and Member of the Board of the charitable Göhde Foundation, established in 2012.
Head of Research and Innovation at Blind Veterans UK. PhD in Regenerative Medicine. Renata worked at King’s College London and at the University of Oxford and is a Senior Lecturer in Haematology and Cardiovascular Sciences. Particular expertise and proficiency in scientific operations in areas of combat and conflict. Named as one of the best Young Scientists in the UK for Science Engineering and Technology. Nominee a finalist for the Wise Hero Science Award in 2014 and one of the 6 Women of the Future (and the only scientist) in the professional category in 2015. Most recently became one of the World Winners of the prestigious Falling Walls Lab.
Bárbara is a researcher expert in proofing care at the end of life to ensure it matches people’s preferences and priorities. Lecturer at the Faculty of Medicine of University of Coimbra and honorary research fellow at the Cicely Saunders Institute of King’s College London. She has led several studies on end of life care. Her research has informed health policy and triggered strategic planning, service developments as well as dialogue with the public and the media about palliative care in Europe and beyond.
Researcher of the Observatory for Migration since 2013, collecting, systematizing and disseminating national and international data on immigration, including the indicators of immigrants’ integration. She has a degree in Sociology and MA in Communication, Culture and Information Technologies. From 2003 to 2006, was research assistant in the Cultural Activities Observatory, and between 2006 and 2012 worked in the area of data collection and analysis in the context of market studies.
Lawrence O. Gostin is University Professor, Georgetown University’s highest academic rank, and Founding O’Neill Chair in Global Health Law. He directs the World Health Organization Center on National and Global Health Law. Gostin is Professor of Medicine at Georgetown University and Professor of Public Health at Johns Hopkins University. The WHO Director-General appointed Prof. Gostin to high-level positions, including expert panels on the International Health Regulations (IHR) and on Mental Health. He served on the Director-General’s Advisory Committee on Reforming WHO, as well as WHO expert advisory committees on pandemic influenza, smallpox, genomic sequencing, and migrant health. He served on WHO’s Blue Ribbon Panel on global health equity. He co-chairs the Lancet Commission of Global Health Law.
Marie-Eve Goyer, MD, MSc, is a general practionner with a master degree in public health. Most of her clinical work is with marginalized population. She is an HIV, HCV and opioid substitution therapy doctor at Montreal universitary hospital outpatient clinic (CHUM) and at the CRAN (center for research and help for opioid users). Sh is medical chief of inner city health and homelessness at CIUSS Centre Sud of Montreal. Dr Goyer is professor in charge at the University of Montreal where she created a new mandatory clerkship named «health inequalities and the social duty of doctors». She is involved with designing new outreach clinics for marginalized populations within the family medicine residency. She is invited professor at the University of Sherbrooke microprogram on addiction for health professionals. She is a medical referent at national institute for public health of Quebec (INSPQ), ministry of health and social services of Québec and Quebec College of physicians (CMQ).
Marcus works as an engaged scholar and urban designer/landscape architect for healthy people and planetary health. Former associate professor and deputy director of the WHO’s Collaborating Centre for Healthy Urban Environments. An expert advisor to the WHO focusing on healthy placemaking for Quito Habitat III, contributions to ‘Health as the Pulse of the New Urban Agenda’ and the European roadmap linking SDGs and Health 2020. He examines sustainable development and health in consultancy, governmental organisations and academia. Editor-in-chief of a new academic journal ‘Cities & Health’.
Assisted in establishing the Office of Orphan Products Development at FDA in 1982, served as the Executive Director of the National Commission on Orphan Diseases from 1987-1989, and served as the Director of NIH’s Office of Rare Diseases Research from 1993-2014 stimulating rare diseases research and developing information for patients, families, health care providers, academic/foundation research investigators, the biopharmaceutical industry, and the public about rare diseases, ongoing and completed research and clinical trials, and patient advocacy groups. Stimulated the development of the Genetic and Rare Diseases Information Center, the International Rare Diseases Research Consortium, the International Conference on Rare Diseases and Orphan Drugs, the Rare Diseases Clinical Research Network, assisting in the development of the Undiagnosed Diseases Program at NIH, and developed common data elements for patient registries. ORDR co-sponsored over 1,300 scientific conferences to assist in identifying research priorities and developing research agendas for the investigation of rare diseases.
Hermann Gröhe is a certified lawyer who has held a seat in the German Bundestag since 1994. He was a spokesperson for human rights and humanitarian assistance in the Bundestag and acted as legal counsel to the CDU/CSU parliamentary group. Gröhe served one year as a Minister of State to the Federal Chancellor, was the CDU Secretary-General and was appointed Federal Minister of Health in 2013.
Dr. Gross is a family physician with a focus on men’s health and HIV. He has a full-time practice at Spectrum Health, a multi-disciplinary primary care clinic, located near St. Paul's Hospital in downtown Vancouver. Since 2009, he has also been working at Vancouver Native Health Society (VNHS) on East Hastings, which provides a full range of health care services to mainly Indigenous people living in Vancouver's Downtown Eastside. He is the Co-Founder and Medical Director of The Dudes Club, an innovative, community-driven men's health program incorporating Indigenous approaches to healing and wellness. He is also Clinical Assistant Professor in the Department of Family Practice at University of British Columbia, where he is involved in teaching and research.
Miguel Guimarães was born in Porto on the 22nd of January 1962. He is the Chairman of Portuguese Medical Association / Ordem dos Médicos – Portugal (2017-2019). Degree in Medicine and Surgery from the Faculty of Medicine of the University of Porto (FMUP). He was director of the Urology Department of the Santa Luzia Hospital in Viana do Castelo - 1999 to 2005. Since then, he has been deemed a Graduated Hospital Assistant in Urology from the Urology Department at the HSJ.
Jörg Hacker was a Professor and Head of the Institute for Molecular Infection Biology at University of Würzburg from 1993-2008 before taking on duties as the President of Germany’s Robert Koch Institute from 2008-2010. He has been a member of the Leopoldina since 1998, and President of the organization since 2010.
Dr. Hader brings to the position more than 20 years of international experience in global health - from responding to HIV and infectious diseases to strengthening health systems. She has served in key health leadership roles emphasizing accountability, scale and impact for sustainable responses. In 2014, Dr Hader was appointed Director of the Division of Global HIV and TB, US Centres for Disease Control and Prevention (CDC) providing technical leadership, funding, evaluation and programme support to help achieve an AIDS-free generation world-wide. Prior to this position, she served as Vice President and Director for the Centre for Health Systems and Solutions at the Futures Group (now Palladium). Dr. Hader also held the position of Senior Deputy Director, HIV/AIDS, Hepatitis, STD and TB Administration for the District of Columbia from 2007–2010 and served as Director of CDC–Zimbabwe from 2003–2006. A public health physician, Dr Hader’s career has reached across research, programme, policy and politics. She holds a degree in Biological Sciences from Stanford University and MD and MPH degrees from Columbia University. Dr. Hader is board certified in Internal Medicine, Paediatrics and Infectious Diseases. The Secretary-General wishes to extend his appreciation to Mr Tim Martineau, who served as Acting Deputy Executive Director, Programme
Dr Assad Hafeez is a leading public health specialist and Paediatrician with extensive clinical and management experience in various capacities, spanning over 30 years. He is currently the Director-General of Health in the Federal Ministry of Health, head of the Health Services Academy and the Dean of Faculty of Medicine in Quaid-i-Azam University, Islamabad. He has been member and then chair of EB WHO and is an adjunct professor in global health department at university of Manitoba, Canada. He is a medical graduate with post-graduate studies in paediatrics; He holds a Fellowship of the College of Physicians and Surgeons, Pakistan and the Royal College of Paediatrics and Child Health, London. He also has obtained a Masters in Epidemiology from the London School of Hygiene & Tropical Medicine and a PhD in Public Health from the University of Manchester in the United Kingdom. He has held a number of clinical, senior management and academic posts in national and international institutions. He is on various international technical organizational boards and editorial boards of reputed journals, in addition to having had more than 100 publications in peer reviewed journals. He is an expert researcher and has completed a number of research grants as Principal Investigator. His main areas of interest are MNCH, health systems, determinants of health, social protection programs and evidence-based policy-making.
Sir Andrew Haines is Professor of Environmental Change and Public Health at LSHTM, with a joint appointment in the Department of Public Health, Environments, and Society and in the Department of Population Health. He was previously Director (originally Dean) of LSHTM for nearly 10 years, and before that Professor of Primary Health Care at University College London. He worked part-time as a general practitioner in North London for many years and has been a member of a number of major international and national committees. Haines was knighted in 2005 for his services to medicine.
Dr Hajjeh is an infectious diseases expert and epidemiologist, and a senior public health leader with extensive experience in global health, health policy and diplomacy. Currently, Dr Hajjeh is the Acting Director of Programme Management at the World Health Organization Regional Office for the Eastern Mediterranean (EMRO), and is also the Director of the Department of Communicable Diseases Prevention and Control. Dr Hajjeh holds a Medical Doctor (M.D.) degree from the American University of Beirut, Lebanon, and has trained in Internal medicine and infectious Diseases at Emory University, Atlanta. Dr. Hajjeh serves as a reviewer for multiple journals, and holds professor positions in medicine and public health at Emory and Johns Hopkins universities.
Dr. Hall joined the International Federation of Red Cross and Red Crescent Societies as Director of Health and Care in 2015, moving to the position of Chief of Staff and Special Envoy for Health in 2017. Dr. Hall qualified as a medical doctor from London University in 1991 and completed her public health physician training in 2003. She began her career in international public health as lead coordinator for WHO during the SARS and Avian Influenza outbreaks in China. She has since continued to work in global health in senior positions including as Global Polio Eradication Lead for UNICEF, as Principal Medical Advisor to the Australian Government and as the WHO Representative in Philippines coordinating the international health response to typhoon Haiyan. In recognition of her services to global health Dr Hall was made a Member of the British Empire in 2007 and awarded the World Association of Disaster and Emergency Medicine Peter Safar Award for disaster medicine in 2017.
Dr. Christoph Hamelmann is the WHO Representative in Iran. He has previously been the director of WHO European Office for Investment for Health and Development in Venice; a center of excellence focusing on determinants of health, health equity and investment approaches for health and well-being in the context of a people-centered approach to universal health coverage. He also led the UNDP Regional Health and Development Programme in Europe, Central Asia and the Arab States, and was the Global Coordinator of the UN Interagency Initiative on Sustainable Procurement in the Health Sector.
Prior to his current position, he used to be Director and Scientific Member at the Max Planck Institute for Chemical Ecology as well as Head of Chemical Ecology at the Swedish University of Agricultural Sciences, Alnarp. He studied biology and was granted his PhD in Ecology.
Dr. Steve Harvey is Dean of the Suliman S. Olayan School of Business, American University of Beirut. Harvey was appointed dean and professor of management in 2016, after having served as Dean of the John Molson School of Business, Concordia University, and Dean of the Williams School of Business and Associate VP, Research at Bishop’s University. Harvey earned his doctorate from the University of Guelph in 1996. Since then, he has been an active scholar, professor, senior executive, and consultant in management and human resources. Harvey’s research has been recognized by various awards, subsidized by several funding agencies, and presented at multiple conferences worldwide. As a strong advocate of the view that practice and research inform teaching, he has been regularly conveying his research findings and practice knowledge within the classroom. He has won several awards for teaching in areas of human resource management, organizational behavior, organizational conflict, and negotiations.
Richard J. Hatchett, MD, is Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership of public, private, philanthropic and civil organizations that finances and co-ordinates the development of vaccines against emerging infectious diseases with pandemic or epidemic potential. Prior to joining CEPI, Dr. Hatchett served as the U.S. Biomedical Advanced Research and Development Authority’s (BARDA) Chief Medical Officer and Deputy Director. Following this he became acting Director of BARDA. Previously, Dr. Hatchett served on the Homeland Security Council under President George W. Bush and was a member of the National Security Staff under President Barack Obama.
The Minister of Health since 2015, he was a Medical Doctor at Namdeb Hospital (Oranjemund-Namibia) from 1997-2001 and Windhoek Central Hospital in 1996. He was the Chairperson of the “Namibia Medical Society” from 2009-2012 and still holds the presidency of the Namibian branch of the “Southern Africa HIV-Clinician Society”.
From 1983 until 2003, Harald zur Hausen was appointed as Scientific Director of the Deutsches Krebsforschungszentrum (German Cancer Research Center) in Heidelberg. He demonstrated in 1983 that cervical cancer in humans is caused by certain types of papilloma viruses (wart viruses), the genes from which are incorporated into the host cells' DNA. This discovery made it possible to develop a vaccine against cervical cancer, which had been the second most common tumor disease in women. For his discovery, he was awarded the Nobel Prize in 2008.
Norbert Hauser’s career in government and public service includes stints as Vice President of Germany’s Supreme Audit Institution, as a member of the high-level panel that created a blueprint for reform at the Global Fund in 2011, and as interim Inspector General at the Global Fund in 2012-2013. Among other positions, he has also served as Chairman of the Panel of External Auditors of the UN and as External Auditor of the IAEA.
Dr Noel Hayman was one of the first two Indigenous medical students to graduate from the University of Queensland in 1990. Noel is Clinical Director of the Inala Indigenous Health Service in Brisbane. In developing this service, he has been instrumental in demonstrating how mainstream primary health care services can be made appropriate to the needs of urban Aboriginal populations. Noel’s interests include improving Indigenous access to mainstream health services and supporting medical education in Indigenous health. Professor Hayman received the 2003 Centenary Medal for his long service to primary health care in Aboriginal communities and the 2007 inaugural Close the Gap Indigenous Health Award (Australians for Native Title and Reconciliation Queensland). In 2011 he was Queensland Australian of the Year. Noel is on numerous National and State Committees.
Marie-Josée Hébert earned a specialized degree in nephrology at the Université de Montréal, followed by postdoctoral studies at Harvard. Dr. Hébert is a researcher and nephrologist-transplant physician at CHUM, professor in the faculty of medicine and holds the Shire Chair in Renal Transplantation and Regeneration. She is also co-director of the Canadian National Transplant Research Program and founder of numerous interdisciplinary and cross-sectoral research groups.Her work has enabled the discovery of new mechanisms at work in the rejection of transplanted organs. In 2015, Dr. Hébert received the Dr. John B. Dossetor Award from the Kidney Foundation of Canada in recognition of her outstanding contribution to research in kidney diseases.
A professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine, he is also chairman of Public Health England, UK. He was the World Health Organization’s Assistant Director-General for Health Security and Environment, representative of the Director General for polio eradication as well as Executive Director of the WHO Communicable Diseases Cluster. He worked for thirteen years in sub-Saharan Africa where he was instrumental in addressing the first and second outbreaks of Ebola Hemorrhagic Fever.
He joined the pharmaceutical industry in 1998 after a ten-year career in Academic Medicine with a focus on internal medicine. He contributed and served in various roles of increasing responsibility at the local, regional and global level in Medical Affairs, Clinical Operations and Patient Safety. He assumed global change management and strategic leadership roles in major organizations.
Karen is Mohawk Turtle Clan from Six Nations of the Grand River Territory in Southern Ontario. She is the mother of 2 boys and step-mother to 5 daughters. She graduated from McMaster University School of Medicine in 2003 and finished her residency in Family Medicine at McMaster in 2005. Karen is the inaugural recipient of the Thomas Dignan award in Indigenous Health – 2015 and is the current Vice President of the Indigenous Physicians Association.
Karen currently works as the Lead Physician with Juddah’s Place (Six Nations of the Grand River Territory), a collaborative primary care practice in partnership with Traditional Medicine Practitioners Elva Jamieson and Valarie King. In her practice Karen utilizes the functional medicine approach to address the complexity of chronic disease and link concepts of genetics, environment and physiology to traditional ways of healing such as food, rest, culture and experience. Karen’s vision is to see traditional knowledge and practice restored to the centre of health care for indigenous people as a key determinant of health and pathway to healing.
Martin Hirsch holds his current position since November 2013. He used to be Head of the Emmaüs France, High Commissioner for Active Solidarity against Poverty, and the High Commissioner for Youth in the government of François Fillon. He holds a master's degree in Neurobiology and is an alumnus of the École Normale Supérieure and of the École Nationale d'Administration.
Dr. Eckart von Hirschhausen studied medicine and science journalism in Berlin, London, and Heidelberg. He specializes in humor as a communication tool in health promotion. Inspired by an interview with Jane Goodall, he's been trying to answer the question: “If human beings are the most intelligent creatures on the planet, why are we destroying our own home?” Eckart von Hirschhausen advocates for governments to make climate policy rooted in medicine and science, and for the medical community to make climate change its number one priority. He is a member of the German Alliance for Climate Change and Health (KLUG), a signatory to "Scientists for Future," and founder of "Doctors for Future." He is also part of the Berlin health consultancy group “Die Brückenköpfe.” Eckart von Hirschhausen has worked as a comedian, author, and television host for over 20 years. His own foundation HUMOR HILFT HEILEN ("Humor Helps Healing") brings laughter to hospitals and promotes research.
Brian D. Hodges MD, PhD, FRCPC is Professor in the Faculty of Medicine and Faculty of Education (OISE/UT) at the University of Toronto; the Richard and Elizabeth Currie Chair in Health Professions Education Research at the Wilson Centre for Research in Education and Executive Vice President Education at the University Health Network (Toronto General, Toronto Western Princess Margaret and Toronto Rehab Hospitals). He leads the AMS Phoenix Project: A Call to Caring, an initiative to rebalance the technical and compassionate dimensions of healthcare.
John is an Ohio Eminent Scholar and Professor of Pediatrics at Cincinnati Children's Hospital Medical Center in the Divisions of Human Genetics and Immunobiology. His lab studies genome biology with a focus on the molecular mechanisms of circadian rhythms in mammals.
Specialized in neglected tropical diseases and vaccine development, Peter Hotez leads the only product development partnership for developing new vaccines for hookworm infection, schistosomiasis, Chagas disease and SARS/MERS. In 2006, he co-founded the Global Network for Neglected Tropical Diseases to provide access to essential medicines for hundreds of millions of people.
Alumnus of Ecole Polytechnique and of AgroParisTech and PhD graduate of Claude Bernard University, Lyon, and former chairman and CEO of the French National Institute of Agricultural Research (Inra), he is now the acting President of Université Sorbonne Paris Cité (USPC).
Dr. Rachel Huxley is Director of Knowledge and Learning, responsible for C40’s knowledge management strategy and research program. Rachel has been with C40 for over 4 years during which time she has developed and led a priority program of research on the multiple benefits of urban climate action and overseen the launch of C40’s flagship Knowledge Hub. Prior to this Rachel was Chief Executive of Peterborough Environment City Trust, leading the Trust’s work on sustainable behavior change and engagement project delivery, as well as, working strategically with city partners to develop a sustainable city plan. As part of her work on sustainable cities Rachel established and led the Sustainable Cities Network, an informal network of leading UK cities to enable sharing of best practice and challenges. Rachel has a PhD from the University of Leeds on the processes and practices of sustainable transition and decision making in cities.
Dr. Adnan Hyder is Senior Associate Dean for Research and Professor of Global Health at the Milken Institute School of Public Health of George Washington University. Previously, Dr. Hyder served as the Associate Chair of the Department of International Health and Director of the Health Systems Program at the Johns Hopkins Bloomberg School of Public Health. For over 20 years, Dr. Hyder has worked to improve global health in low- and middle- income countries across Africa, Asia, Latin America, and the Middle East; and pioneered empirical work around health systems, ethics, and injury prevention in the developing world. He has co-authored over 300 scientific peer-reviewed papers and numerous world reports with organizations like the World Bank, World Health Organization and UNICEF.
Dr. Charles Ibingira is the Principal, Makerere University College of Health Sciences. Before ascending to this office, he was the Dean School of Biomedical Sciences at the College of Health Sciences. Dr. Ibingira is an active General Surgeon and an Assoc. Professor of Anatomy and is a senior researcher in surgery, anatomy, and bioethics. He has mentored and supervised several graduate students and junior faculty and published several papers in international journals.
An Infectious Disease Epidemiologist and consultant in Public Health Medicine, he used to be the Managing Partner at EpiAfric, worked as co-Director of the Centre for Tuberculosis at the South African National Institute for Communicable Diseases, and was a Consultant Medical Epidemiologist with the UK's Health Protection Agency and at Germany’s Robert Koch Institute. His scientific research has been focused largely on intervention epidemiology.
Ambassador Ischinger is Chairman of the Munich Security Conference (MSC) and Senior Professor for Security Policy and Diplomatic Practice at the Hertie School of Governance in Berlin. He has served as German Deputy Foreign Minister (State Secretary) and as Germany's Ambassador in Washington, D.C. and London. In 2015, he chaired an OSCE-mandated ‘Panel of Eminent Persons on European Security as a Common Project’. From 2008 to 2014, he was also Global Head of Government Relations at Allianz SE, Munich. He is a member of a number of non-profit and corporate boards.
Dr. Jayasree K. Iyer leads the Access to Medicine Foundation as Executive Director, directing strategy, stakeholder dialogues, and research programs. As a spokesperson, she is actively involved in stimulating change within the pharmaceutical industry. She has worked at the interface of the global health community and the pharmaceutical industry for 12 years. Before joining the Foundation, Iyer was responsible for creating, negotiating, and managing public private partnerships in R&D for infectious diseases and oncology. She has worked at NGOs, academic institutions and think tanks.
Joke Jaarsma is treasurer of the European Brain Council (EBC), the umbrella organization bringing together all major stakeholders in the field of brain research. EBC brings together science & society in order to advance understanding of the healthy and diseased brain and to improve the lives of those living with brain disorders. Its members come from a wide range of organisations, from science, policy, industry, and patient organisations.
After graduating from Tehran University of Medical Sciences (TUMS) in 1992, he was appointed as faculty member in the General Surgery department in 1999. His focus of research are Hepatopancreatobiliary Surgery and Liver Transplantation. He was executive advisor for the Chancellor of TUMS from 2005-2008, Dean of the Medical School from 2008-2009, Vice Chancellor from 2009-2011, and appointed as Chancellor in 2013.
Marjeta JAGER is Deputy Director General for the Directorate-General for International cooperation and Development (DG DEVCO) of the European Commission. Previously, Ms Jager served as the Director for Policy Coordination and Security in the Directorate-General for Mobility and Transport of the European Commission. She held that role from 2012 to 2015, with the exception of the first months of the current Commission when she was requested to take time out in order to set up the Cabinet of the incoming Commissioner responsible for Transport, Ms. Violeta Bulc, during which time Ms. Jager assumed the role of Head of Cabinet. Prior assignments in the Commission, which Ms Jager joined in 2005, include two Director positions in the former Directorate-General for Energy and Transport; first in leading policy in security for energy and transport (2005-2008) and second in taking responsibility for several fields including policy for international energy and transport, passengers' rights issues, and overall coordination in the Directorate-General (2008-2011). Before joining the Commission, Ms Jager held the following positions: Deputy Permanent Representative, Minister Plenipotentiary - Coreper I Representative of the Republic of Slovenia to the European Communities (2002-2005); State Under-Secretary in the Cabinet of the Minister of Foreign Affairs (2002); Head of Cabinet of the Slovenian Minister for European Affairs (2000-2002); First Secretary at the Slovenian Mission to the European Communities (enlargement, II and III pillars, 1995-2000); Counsellor at the Ministry of Foreign Affairs of the Republic of Slovenia, responsible for relations with the European Union (1991-1995). Ms Jager holds a Bachelor Degree in Law and International Law from the University of Ljubljana and is a barrister.
Zsuzsanna Jakab has engaged first hand with many partners and WHO member states, contributing to the formulation of a joint health agenda for the WHO European Region and working for the WHO Europe in a range of senior management roles. Between 2002 and 2005, she was State Secretary at the Hungarian Ministry of Health, Social and Family Affairs. Prior to that, she served as the founding Director of the European Union's European Centre for Disease Prevention and Control in Stockholm, Sweden.
Dr Mohammad Jalili is an emergency medicine specialist by training and works as the attending physician in the emergency department of a large tertiary hospital in Tehran, Iran. He works as the professor of emergency medicine department and medical education department in Tehran University of Medical Sciences. He served as the director of the Educational Development center from 2009 till 2011 and as the vice-chancellor for education from 2011 till 2017.
He is Professor Emeritus of Global Health at the University of California, San Francisco, as well as at the University of Washington, Seattle. He served as the T. & G. Angelopoulos Visiting Professor of Public Health and International Development in the Harvard Kennedy School and the Harvard School of Public Health. Previously, he has worked at the University of California, Los Angeles, and held the position of Director of the World Development Report Office at the World Bank.
After completing his medical degree at Monash University, Stephen Jane spent five years in the US. He returned to Australia in 1995, and took on duties as director of the laboratories at the University of Melbourne in 2000. He was subsequently appointed Head of Monash University’s Central Clinical School and Director of Research for Alfred Hospital in 2011. Jane’s research interests encompass developmental and acquired disorders, as well as gene transcription.
Commodore Jesus Silva is graduated in Medicine and Surgery by University of Coimbra. He joined the Navy in 1988, as Naval Reserve Officer, and the Permanent Board of Officers, at Navy Physicians Class in 1989. He is specialized in Stomatology, Hospital of S. José, in Lisbon and qualified with the degree in Consultant of Stomatology and Subspecialist in Orthodontics. As Naval Medical Officer, he was Deputy Director and Director of the Center of Naval Medicine and President of the Naval Health Board. As Commodore, Jesus assumed the position of Director of Health on January 11, 2017.
A practicing general internist at the VA, Ashish Jha is the K.T. Li Professor of Health Policy at the Harvard T.H. Chan School of Public Health, and a newly elected member of the Institute of Medicine. His work has focused on the primary areas “Public reporting”, “Pay for performance”, “Health information technology” and “Leadership“.
Dr. Taufique Joarder is serving as the Research Director, USAID’s Multisectoral Nutrition Project, FHI 360, Bangladesh Office. He completed his Doctorate in Public Health (DrPH) from Department of International Health at Johns Hopkins Bloomberg School of Public Health, and has been involved as an Associated Faculty in its Health Systems Program. His areas of interest include health and nutrition policy, health systems, human resources for health, medical anthropology, mixed methods research, implementation science, and psychometrics.
Blending a deep background in healthcare-focused technology, he leads Microsoft’s collaboration with an ecosystem of partners around the world to provide solutions that meet the specific needs of customers working to deliver better health outcomes for more people. Before assuming his current role, he was the head of Healthcare at Microsoft UK. He joined the company in 2000. Prior to that, he worked at IBM Software Group UK.
Didier Jutras-Aswad is an addiction psychiatrist and researcher at the CHUM Research Centre. He is a Clinical Associate Professor at Université de Montréal and is also affiliated with Mount Sinai School of Medicine in New York. He is the director of the Addiction Psychiatry Unit at the CHUM, a specialized program for patients with addiction, mental health disorders and physical comorbidities. His research focuses on developing new interventions for addiction and comorbid conditions. He is particularly interested in cannabinoids, both for their deleterious effects and their therapeutic properties. He holds several research grants from funding agencies and is the principal investigator for various clinical trials in the addiction field. He is also involved in several research networks around themes affecting vulnerable populations such as substance misuse, HIV, hepatitis C and suicide.
Dr. Natalia Kanem is the Executive Director of the United Nations Population Fund (UNFPA), the United Nations sexual and reproductive health and rights agency. Appointed by United Nations Secretary-General António Guterres in 2017, Dr. Kanem has more than 30 years of strategic leadership experience in the fields of preventive medicine, public and reproductive health, social justice and philanthropy. Dr. Kanem holds a medical degree from Columbia University in New York, and a Master’s degree in Public Health with specializations in epidemiology and preventive medicine from the University of Washington in Seattle. She is a magna cum laude graduate of Harvard University in history and science.
Prior to his assuming the role of President and CEO at the Association of Academic Health Centers in July 2018, Steven L. Kanter, MD, served as dean of the University of Missouri-Kansas City School of Medicine, where he was professor of medicine and biomedical and health informatics and he held the Merl & Muriel Hicklin/Missouri Endowed Chair in Medicine. Dr. Kanter draws from a diverse background of experience that includes clinical medicine, medical informatics, scholarly publishing, medical school administration, and academic health center growth and development.
Dr. Selma Karabey is Professor of Public Health at Istanbul University. She currently serves as the Chair of Post-graduate Education Program on Public Health at the Istanbul Medical Faculty and the members of National Committee of Program Developing on Public Health Post-graduate Education. She has worked as a Senior Advisor of National Program on Multi-sectoral Health Approach leaded by the Turkish Ministry of Health and has been acting as a board member of BirIZ Association which is performing community mental health. Her major interests are mental health promotion and social policies in health.
After holding several positions including Staff Scientist at the Max Planck Institute for Immunobiology in Freiburg and Chair of the Department of Immunology at the University of Ulm, he became the Founding Director of the Max Planck Institute for Infection Biology in Berlin. Since 2019 he is Director Emeritus at this institute. The Microbiology and Immunology expert is a member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) and the German National Academy of Sciences Leopoldina.
Geoffrey Kelley holds a bachelor’s degree in history and a master’s degree in modern Canadian history from McGill University. He taught for 15 years before joining Alliance Québec for several years, then became a political attaché and chief of staff. He oversaw questions such as education, higher education, the Charter of the French language, municipal affairs and public security.
He was initially elected MNA for Jacques-Cartier in 1994. He subsequently chaired a number of committees, including the Committee on Public Administration, the Committee on Social Affairs, the Committee on Education, the Committee on Health and Social Services, and the Select Committee on Dying with Dignity. He served several times as official opposition critic for Aboriginal affairs, the Far North and the family and was also responsible for relations with the English-speaking community. He has achieved recognition above all for his role as Minister for Native Affairs and Minister responsible for Native Affairs, a position that he has occupied several times. He is serving his seventh consecutive mandate as MNA for Jacques-Cartier. In April 2014, he was appointed Minister responsible for Native Affairs for the third time.
Yan Kestens is an Associate Professor at the Ecole de Sante Publique de l’Université de Montréal and a researcher at the Research Center of the Montreal University Hospital. He holds a Canadian Institutes of Health Research Applied Public Health Chair in Urban Interventions and Population Health. His program of research is exploring how urban change impacts health profiles and health inequities. Through methodological innovations that improve our capacity to assess urban interventions as well as people’s interactions with urban spaces, the Chair contributes to understand how ‘environments get under the skin’, and works in collaboration with local and regional decision makers to generate relevant evidence helping design healthier and more equitable cities.
Professor Mohammad Reza Khami, born in 1978, got his Doctor of Dental Surgery (DDS) degree from Tehran University of Medical Sciences (TUMS) in 2002, and his PhD in Community Oral Health from University of Helsinki in 2007. He currently works as a full professor in Community Oral Health Department, TUMS School of Dentistry, and the head of Research Center for Caries Prevention, Dentistry Research Institute of TUMS. He also is the Chief Consultant of Vice-chancellor for Global Strategies and International Affairs, TUMS.
Mehrnaz Kheirandish (MD, PhD) is the Director General for Assessment and Control of Prescribing and Use of Medicines and Health-Related Products, in Iran Food and Drug Administration (Iran FDA). In her current responsibility, she leads the following programs in Iran FDA: Health Technology Assessment (HTA); Rational Use of Medicines (RUM); Hospital pharmacies; Pharmacovigilance center (including ADR); and the pharmaceutical care standards. She was previously the Secretary of the Biosafety Committee of Ministry of Health and Medical Education.
Prof. Ilona Kickbusch’s work focuses on the political determinants of health, health in all policies, and global health. She established the Global Health Centre at the Graduate Institute and served as its director until 2019. She advises countries on global health strategies and trains health specialists and diplomats in global health diplomacy. Among other positions, Kickbusch is a member of the Global Preparedness Monitoring Board and the WHO High-Level Independent Commission on NCDS and is co-chair of UHC 2030. She acts as Council Chair to the World Health Summit in Berlin. She has had a distinguished career with the WHO and chairs the international advisory board for the development of the German global health strategy.
Alexandra King, MD, FRCPC, is a member of the Nipissing First Nation (Ontario). She is an Internal Medicine Specialist with a focus on HIV/AIDS, hepatitis C (HCV) and HIV/HCV co-infections. She works at the Lu’ma Medical Centre, an Indigenous health and wellness centre providing excellence in wholistic care using both Indigenous and Western healing approaches. As a First Nation researcher, Alexandra is a Principal Investigator on various CIHR research grants related to Indigenous people and HIV, HCV and co-infections. Other research interests include Indigenous wellness; Indigenous research ethics; peer-based navigation, support and research; landbased cultural healing and wellness retreats; and land-based research. She works in communitybased research and intervention research grounded in Indigenous epistemology, culture and wellness. She serves on many local and national initiatives, including the CanHepC: the Interagency Coalition on AIDS and Development, and the CIHR Canadian HIV Trials Network (CTN) Working Group for Health for People Who Use Drugs (co-lead), and the CIHR HIV/AIDS Research Advisory Committee (CHARAC).
Dr. Malcolm King, a member of the Mississaugas of the New Credit First Nation, is a health researcher at Simon Fraser University, joining the Faculty of Health Sciences in September 2012. Over a long career in pulmonary research, Malcolm has developed new approaches to treat mucus clearance dysfunction in chronic lung disease, and continues to work on addressing issues in airborne disease transmission.
From 2009 to 2016, he led the CIHR Institute of Aboriginal Peoples’ Health as its Scientific Director, spearheading the development of a national health research agenda aimed at improving wellness and achieving health equity for First Nations, Inuit, and Métis Peoples in Canada. His international Indigenous health interests include improving Indigenous health through workforce development and provision of culturally appropriate care, and developing Indigenous health indicators to monitor progress in programs aimed at achieving wellness and health equity. Dr. King was honoured with a National Aboriginal Achievement Award in 1999, and in 2016 was named a Fellow of the Canadian Academy of Health Sciences.
Dr. Bronwyn King is a specialist radiation oncologist and founder and CEO of Tobacco Free Portfolios. She is also a Tobacco Control Ambassador for Cancer Council Australia and Diplomat of the Global Charter for World Federation of Public Health Federations. Dr. King has delivered two TEDx talks in the past year, calling for change in the global finance sector. A former elite swimmer, she was previously Team Doctor for the Australian Swimming Team.
A world renowned kidney disease epidemiologist, his scientific contributions have aided in the prevention and epidemiology of kidney disease, hypertension and cardiovascular disease. He led pioneering studies in kidney disease epidemiology, including the first study to assess the incidence of end-stage renal disease and to identify blood pressure as a risk factor for the development of kidney failure.
He leads the Wellcome Trust’s expanding policy and advocacy activities on antimicrobial resistance, as a key part of the organization’s five year, £175m commitment. He joined in July 2017 after eight years working in government at the UK Department for Health. Having originally studied economics at the University of Nottingham, he recently completed a master’s degree in Health Policy at Imperial College, London
A fully qualified lawyer, she joined the Federal Ministry of Labor and Social Affairs in 1989 and from 1992 to 1995, she was seconded to the European Commission in Brussels. Since February 1995, she has held various functions at the Federal Ministry of Health. In 2005, she was appointed Director General for Matters relating to Disabled Persons, Social Assistance at the Federal Ministry of Health and Social Security.
Gary Kobinger is a professor in the Department of Microbiology and Infectious Diseases and the Director of the Research Centre on Infectious Diseases, Faculty of Medicine at Université Laval. He is also an adjunct professor in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania, and an associate professor in the Department of Medical Microbiology at the University of Manitoba. His work focuses on developing and testing new vaccine platforms and immune treatments against emerging and re-emerging viruses of high consequences to public health.
Between 2013-2016, 60 minutes, National Geographic, BBC Horizon, NOVA, France 2, PBS and others featured the leading work on successful treatment of Ebola infection that was developed by Gary and his team. In July 2016, Gary Kobinger initiated a new chapter of his career as the Director of the Centre de Recherche en Infectiologie de l’Université Laval.
Meri Koivusalo has expertise in global and transnational health and social policy, trade and global governance for health. She is "globally" interested in global health issues, but she has a particular interest in the relationship between economic globalization, trade and health, health systems and politics and practice of global health policy-making. Meri has a background in public health medicine with a PhD in environmental health and MSc from London School of Hygiene and Tropical Medicine. She has co-authored and edited academic and textbooks in the area of global health as well as worked with Finnish government, European Commission, WHO-Geneva, UNRISD and a number of international nongovernmental organizations. Meri is currently member of the WHO expert panel on science and technology.
A biochemist and professor of structural biology, he was awarded the Nobel Prize in Chemistry for his studies of the process by which genetic information from DNA is copied to RNA. Kornberg became a postdoctoral research fellow in Cambridge, England, and then an Assistant Professor of Biological Chemistry at Harvard Medical School in 1976. In 1978, he moved to his present position as Professor of Structural Biology at Stanford Medical School.
After earning a doctorate in medicine in 1997 from the University of Münster in Germany, he treated cancer and leukemia patients in the university hospital's department of internal medicine, most recently as senior physician. After eight years of clinical practice, he made the transition to the research-based biopharmaceutical industry. He joined Pfizer in 2010 as Commercial Lead Pfizer Oncology Europe, Hematology. Since June 2016 he is Vice President Commercial Portfolio Management Pfizer Oncology Europe, Japan, South Korea & Australia / New Zealand.
Monika Kosinska is the Programme Manager for Governance for Health and Regional Focal Point for Healthy Cities, supporting Member States across the European region in improving governance for health and well-being for all. She was Secretary General of the European Public Health Alliance, a leading Brussels-based NGO in the global health area. Previously she held a number of positions within the public and private sector.
Alexander Krämer is an expert in the field of Public Health with background in internal medicine and epidemiology, and one of the founders of the first School of Public Health in Germany at Bielefeld University. His research fields consists of a global public health perspective: urban health, climate change, infectious diseases and refugee health. As senior professor, he is the director of the Graduate Research Programme FlüGe at Bielefeld University, Germany, addressing refugee health from inter- and trans-disciplinary views.
Prior to joining the WHO, he was in charge of German International Cooperation’s (GiZ) work on social protection at its headquarters in Germany and in India. With a solid background in public health,he has also held various management positions at the WHO Regional Office for Europe in Copenhagen in the fields of health systems, health policies and health promotion.
José Eduardo Krieger is Professor of Genetics and Molecular Medicine at the University of São Paulo Medical School and Director of the Laboratory of Genetics & Molecular Cardiology at the Heart Institute (InCor). He is the President of the State of Sao Paulo Academy of Science and regular member of the Brazilian Academy of Science.
Frederik Kristensen, MD has been the Deputy CEO of CEPI since January 2017. Before joining CEPI he was a senior advisor on innovation at the World Health Organization in Geneva, in the Family, Women’s and Children’s Health Cluster. Dr. Kristensen is a healthcare executive with previous experience from the Norwegian Development Agency, hospital management and the pharmaceutical industry. He has started and run successful companies in the areas of health economics and decision support. At the start of his career he worked as a general practitioner in rural settings. He is an MD from the Universities of Oslo, Norway and Newcastle-upon-Tyne, UK, with a MPH/MBA degree from the University of California, Berkeley.
She began her career in 1995 at ABB Daimler Benz in New Delhi, India. Subsequently, she worked for the Boston Consulting Group, was Head of Linde Healthcare Europe, and moved to Dräger as Member of the Executive Board, responsible for Sales and Marketing. She was appointed Executive Vice President and Chair of the Management Board of Philips Deutschland GmbH and Chair of Philips DACH and is also a member of the Supervisory Board of Zeiss Meditec and Save the Children e.V.
Prof. Heyo Kroemer assumed his role as CEO of Charité Universitätsmedizin Berlin in September, 2019. He was previously Chairman of the Managing Board of the Göttingen University Medical Center and Dean of the Faculty of Medicine at Georg-August-Universität Göttingen. Prof. Kroemer’s medical background is in pharmacology, with a research focus on drug metabolism and transport.
Susanna Krüger is CEO at Save the Children Germany e.V. since March 2016. Before she founded and led GoodRoots, an advisory firm working with social investors on their impact measurement and organizational change. Susanna's work experience includes over 16 years in development cooperation as well as humanitarian aid and its evaluation (Middle East, Asia and Africa), public administration reform, facilitation of organizational change in the non-profit sector, strategic philanthropy and impact investing efforts with large European foundations. Susanna holds master's degrees in history, philosophy and international law from the Free University in Berlin and in public administration from Harvard University.
Trained in economics and management, Suresh Kumar has more than 30 years of experience in the healthcare industry. Beginning in 1978 in India, he held senior roles in consumer healthcare in Canada, North America, Latin America and Asia. In 2010, the United States Senate unanimously confirmed him as Assistant Secretary of Commerce and Director General of the U.S. and Foreign Commercial Service.
Dr. Ann Kurth is an epidemiologist and nurse-midwife whose research focuses on global health system strengthening, in the context of climate change and other planetary stresses. She is Dean and Lorimer Professor, Yale University School of Nursing (YSN); a Fellow of the National Academy of Medicine, and of the American Academy of Nursing; and chair of CUGH, and of the National Academy of Medicine Board on Global Health, 2018-2020.
Now on his second five-year term as Director General, William Lacy Swing has been an ambassador six times during his long diplomatic career at the US State Department. His experience widely consists of managing some of the largest diplomatic missions, foreign development and humanitarian aid programs across the hemispheres. He was re-elected as IOM’s Director General in 2013, a position he has held since October 2008.
Chi-Wan Lai, M.D. graduated from the National Taiwan University (NTU) College of Medicine (1969). He received residency training in the Department of Neurology & Psychiatry in NTU Hospital (1970-1974), and then residency and fellowship in the Department of Neurology University of Minnesota (1975-1979). He was the Professor of Neurology at the University of Kansas when he returned to Taiwan in 1998. Since then, he had been the dean of Tzu-Chi University College of Medicine (1998-2001), Executive Secretary and then Chairman of the Medical Education Council, Ministry of Education of Taiwan (2002-2012). Since Taiwan Medical Accreditation Council (TMAC) was established in 2000, he had been a council member, and became CEO (2006-2012), and then Chairman (2012-2015) until he retired from TMAC in 2015.
In 2004, Marie-France Langlet's nine-year-old son, Lucas DiTecco, was diagnosed with acute nonlymphocytic leukemia at the Centre Hospitalier Universitaire Ste-Justine (CHUSJ), where he would go through several chemotherapy treatments. Unfortunately, chemotherapy would not be sufficient to keep him in remission. He would then receive a bone marrow transplant in 2005. From the beginning and throughout the hospitalization and follow-up process, Marie-France was profoundly involved in the treatment, in close partnership with the healthcare personnel. From the beginning, she also felt the need to help other parents who shared her struggles as they fought for their child's return to health and happiness.
Since her son's complete recovery in 2013, Mrs. Langlet has been an active participant in numerous initiatives concerning patient partnership at the CHUSJ, particularly within the oncology department. She has also joined the Comité des usagers du CHUSJ since 2014. Finally, along with the Direction collaboration et partenariat patient (DCPP) and the Université de Montréal, she has been involved in educational projects on healthcare partnership that target both the general population and the community of healthcare professionals. Her son's exceptional courage and determination have been her greatest source of inspiration. Over the years, she has attempted to celebrate him through her involvement, passing it forward and lending her support to those who have dedicated their lives to caring for our children. Mrs. Langlet has been blessed with a creative spirit, a gift for organization, the will to act, and an extensive management experience in the great enterprise that inspires her to devote her strength and her conviction to her cause.
An anthropologist and expert for infectious disease epidemiology, she headed the Global Immunisation Communication at UNICEF, chaired GAVI’s Advocacy Task Force, and served on the WHO SAGE Working Group on vaccine hesitancy. Her research focuses on the analysis of social and political factors that can affect uptake of health interventions and influence policies. Her particular interest is on risk and rumor management from clinical trials to delivery as well as building public trust.
Stefan Larsson is the global leader of BCG's Health Care Payor and Provider sector, as well as a member of the group’s Global Health Care leadership team. His work involves him in nearly every aspect of the healthcare industry, and his experience includes leading a cross-industry consortium to define a healthcare outcomes strategy for Sweden.
He brings expertise in global revenue management, product innovation, corporate strategy, organizational and mergers, as well as acquisition to his role at SAP. Previously, he served as CEO of Sutherland Healthcare Solutions and worked at Cognizant as the Managing Director of the Healthcare Innovation Digital Ventures and Global Director of Strategy.
John Lavis holds the Canada Research Chair in Evidence-Informed Health Systems. He is the Director of the McMaster Health Forum, Co-Director of the WHO Collaborating Centre for Evidence-Informed Policy, and Professor in the Department of Health Evidence and Impact at McMaster University. Dr. Lavis supports policymakers and stakeholders to harness research evidence, citizen values and stakeholder insights to strengthen health and social systems and get the right programs, services and products.He holds an MD from Queen's University, an MSc from the London School of Economics, and a PhD in Health Policy from Harvard University.
Dr. Pattara Leelahavarong, a Program Leader of HITAP, is a Ph.D. graduate in Health Economics from the University of Glasgow. She has worked for Health Intervention and Technology Assessment Program (HITAP) as a researcher in 2008 in the area of health technology assessment (HTA) using economic modelling including pharmaceutical, medical devices, and health promotion programs. She has also been involved in the national policy decision making process as a member of the Health Economic Working Group and Price Negotiation Working Group under the Subcommittee of National List of Essential Medicine which HTA.
Branka Legetic is medical doctor, and public health specialist with masters degree in cardiovascular prevention and doctorate in noncommunicable disease prevention and control. She has served in the Institute of Public Health for the former Yugoslavia, continuing as regional advisor and head of unit of Noncommunicable diseases covering North and South America and Caribbean at PAN American Health Organization. She is currently a professor of Social Pharmacology at the School of Pharmacy in Novi Sad, Serbia and Professor in Health Management at European Center for Peace and Development affiliated to UNESCO.
Ricardo Baptista Leite MP, MD is a Medical Doctor (ID-trained), member of Portuguese Parliament (Health and Foreign Affairs Committees) and National Spokesperson for Health of Social Democratic Party. He is the President of ‘UNITE – Parliamentarians Network to End HIV/AIDS, Viral Hepatitis and Other Infectious Diseases’; a global platform of parliamentarians committed to ending HIV/AIDS, viral hepatitis and other infectious diseases as global health threats by 2030. He is one of six people acknowledged globally by ‘The Economist’ as a ‘HCV Change Maker’ and is the Head of Public Health at Católica University of Portugal, Coordinator of Sustainable Healthcare at NOVA Information Management School and Guest Lecturer at NOVA Medical School. He has also served as the former Deputy Mayor of the city of Cascais.
MD, PhD. Oncologist and basic chronobiologist. Professor of Biomedicine - Oncology at the University of Warwick Medical School. Coordinator of the Warwick-INSERM European Associated Laboratory "Personalising Cancer Chronotherapy through Systems Medicine (C2SysMed)". He has been the chief investigator of nearly 40 clinical studies including international Phase III trials of chronotherapy. Founding member of the National Academy of Technology of France, where he coordinates the Domomedecine initiative. Over 400 scientific publications and 600 communications to scientific congresses.
Lawyer by training, he worked at the International Committee of the Red Cross on field missions as delegate, chief of under-delegation, legal advisor for Asia and Latin America, representative of the ICRC at the United Nations in New York, and was in charge of policies for the disabled and substance dependence. In 2004, he became Director General of the Hospice General. In 2013 he was appointed new Director General of the Geneva University Hospitals.
Catherine Levy, as Head of Global Health Programs for Non-communicable Diseases is in charge of the development and implementation of NCD programs with a specific focus on diabetes & cardiovascular disease. Pharm D, PhD by training, Catherine has been involved in diabetes for the last 10 years, working closely with emerging countries and developing diabetes access, capacity building and training projects in close partnership with health care providers, patient associations, governments and NGOs.
Paul Lewis is a full professor of urban planning at the Université de Montréal, where he lectures about transportation and health. In 2014, he became the Dean of the Faculty of Environmental Design, which brings together three schools: the school of architecture, the school of design, and the school of urban planning and landscape architecture. Before joining the Université de Montréal, he worked as an urban planner for the Hull and Gatineau municipalities, as well as the Ministry of Municipal Affairs in Quebec, at the head of Land Use Planning. He has also worked at the Council of Universities as a researcher. His main fields of interest include urban planning, transportation planning and human mobility. Among other subjects, he has studied the evolution of retail and the development of traditional commercial districts. He has also researched transit-oriented development and its impact on human mobility. More recently, he has studied the mobility of primary school students in the Montreal and Trois-Rivières regions, the development of intermodal transport hubs, and parking policies.
Dr Jerker Liljestrand is Deputy Director in Maternal, Newborn & Child Health, and lead on maternal health at the Bill & Melinda Gates Foundation. He is an ob-gyn, who started off his international health work in Mozambique. He has worked with sexual and reproductive health and rights in 30+ countries for various organizations e.g WHO, the World Bank, and UNICEF; and most recently in Cambodia on MNH/FP. His work has spanned from HIV/AIDS, adolescent SRHR and midwifery, to health systems for MNH.
Maria is the National Health Director of Cape Verde. Medical doctor with specialization in Public Health and occupational Medicine. Her Master’s studies focused on Health and Development and she has several post-graduate studies. Maria was awarded with the Francisco Cambournac reward for being the best student on the Public Health Master (Health and Development branch). Former director of Health Centers in Praia and of several public health programs: tuberculosis, leprosy, cancer and diabetes.
Professor Depei Liu's central research interests are medical molecular biology and research in gene regulation. He executes various prestigious positions, including former President of the Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC).
Trained at McGill University School of Medicine and specialized in pediatrics at Montreal’s Sainte-Justine hospital, she holds a fellowship in pediatric emergency medicine from New York University School of Medicine, and an International Master’s in Health Leadership from McGill University. She is also an associate professor at the University of Montreal and a professor in practice at McGill University. She has worked in many conflict zones, including in Palestine, Central African Republic, DRC and Sudan’s Darfur region.
David Loew is currently Executive Vice-President of Sanofi Pasteur, the vaccines Global Business Unit of Sanofi, and a Member of the Executive Committee of Sanofi. Sanofi Pasteur manufactures and markets a diverse portfolio of vaccines, including influenza, meningitis, travel and endemic diseases. Sanofi Pasteur is a world leader in influenza and pediatric vaccines, and the first worldwide supplier of polio injectable vaccine. The vaccines help protect as many as half a billion lives each year against life-threatening diseases. Loew joined Sanofi in 2013 as Senior Vice-President of Commercial Operations, Europe, responsible for the pharmaceutical business across 38 countries. Before working for Sanofi, he spent 20 years with Roche, latterly as Region Head, Eastern Europe, Middle East and Africa and Global Chief Marketing Officer for the pharmaceutical division. Loew is a member of the Vaccine CEO Steering Committee, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), and a former Member of the Board at GAVI
Professor Lai-Meng Looi has served as Chair of Pathology; Deputy-Dean (Postgraduate); Medical Research Committee Chair; and Medical Ethics Committee Chair. She is devoted to promoting a research and ethical culture among young scientists.
He joined UNAIDS in 1996 and was appointed Deputy Executive Director of Programme and Assistant Secretary-General of the United Nations in January 2013. He leads UNAIDS’ efforts in leveraging critical support to countries to meet the 2015 global AIDS targets and establish a sustainable response to AIDS. He is a medical doctor with nearly 30 years of experience in the AIDS response sector.
Christian Luft has been State Secretary at the Federal Ministry of Education and Research (BMBF) since October 2018. Previously, he was Head of Department for Social, Health, Labour Market, Infrastructure and Social Policy at the Federal Chancellery, where he was also responsible for Education and Research. Christian Luft has many years of experience in federal and state administration, including previous positions at the Federal Chancellery, Federal Ministry of Labour and Social Affairs, and Baden-Württemberg Ministry of Labour and Social Affairs.
Michael T. Lynskey. Ph.D. is a Professor of Addictions at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London. He completed his training in New Zealand, working on the Christchurch Health and Development, a longitudinal study of 1265 children, and has held academic appointments at the National Drug and Alcohol Research Centre, University of New South Wales and in the Dept. of Psychiatry at Washington University School of Medicine in St Louis, Missouri. Michael has published extensively in the field of longitudinal studies and developmental psychopathology, with a particular emphasis on issues relating to cannabis use and cannabis use disorders, including the epidemiology and etiology of cannabis use and dependence; the assessment of cannabis use disorders, the comorbidity between cannabis use and mental health, and the genetics of cannabis dependence
MD, Master Degree in Public Healh and PhD. Director of CISM. Chair of National Commission for Polio Eradication in Mozambique. Member of the National Advisor Committee on Immunization. He has participated in the design, implementation and analysis of several clinical trials, including evaluation of intermittent treatment in infants, and the evaluation of malaria vaccine in Mozambique. Vice-Chairperson and representative of Mozambique at the EDCTP General Assembly.
Alex MacKenzie, an attending pediatrician at the Children’s Hospital of Eastern Ontario (CHEO) in Ottawa Canada has served as the CEO and Science Director of the CHEO Research Institute as well as Vice President of Research for both CHEO and Genome Canada in addition to being founding scientist of the AeGera biotech company. Dr. MacKenzie’s laboratory has conducted translational research on the rare pediatric disorder spinal muscular atrophy over the past 25 years; in recent years has broadened its focus with its involvement in the enhance Care for Rare project to search for therapies for a larger number of rare diseases. He is also looking at means of identifying and possibly presenting fetal alcohol syndrome disorders.
A nationally renowned researcher and a veteran academic leader, her research focuses on the impact of health services and policies on the short-and long-term consequences of traumatic injury. She has contributed to the development and evaluation of tools for measuring both the severity and outcome of injury which have been used to evaluate the organization, financing and performance of trauma systems and rehabilitation services.
Head of Pediatrics and Neonatology at the Mongi Slim University Hospital, La Marsa, Tunisia, Dr. Ahmed Maherzi is a member of the mother-child network of French-speaking countries . In terms of professional affiliations, he has been a member of the Board of Directors of the Francophone Pediatric Hepatology, Gastroenterology and Nutrition Group, Secretary General of the Tunisian Society of Pediatrics, and a member of the Executive Committee of the Panarab Society of Pediatric Gastroenterology, Hepatology and Nutrition. He’s member of the permanent office of the International Conference of Francophone Deans and member of the scientific council of the University Agency of Francophony. With regard to his academic career, he has been Dean of the Faculty of Medicine of Tunis since 2011. His interest in social accountability led him to become Co-Chair of the International Francophone action research project on the social accountability of medical schools. He received the AFMC-Charles Boelen International social accountability award in 2016. Organizer of The World Summit of Social Accountability, 8-12 April 2017, Hammamet (Tunisia).
He holds a MBChB from the University of Nairobi; MSc (Med. Sci) in Genetics from the University of Glasgow and is an alumni of the Strathmore University/ IESE University of Navarra Advanced Management Program. He started his career as a Medical Officer at Kenyatta National Hospital where he rose to the position of Consultant Geneticist and Quality Assurance Manager and worked with WHO and UNICEF on local and international assignments.
Dr. Wahid Majrooh is a technical adviser, international relations director, spokesperson, and senior international relations adviser to H.E the Minister of Public Health of Islamic Republic of Afghanistan. He is a graduate of the medical faculty of Herat University in 2008 and has worked in different senior management positions with International Aid and Diplomatic agencies. As a youth entrepreneur, Dr. Wahid Majrooh has established Creative Youth Private School, Creative Youth Private Preschool and recently the first high tech Mother and Fetal Diagnostic center “AfMed Superspeciality Ultrasound Clinic” in Kabul, Afghanistan.
Dr. Makanga is the Chief Executive Officer of the EDCTP Association Secretariat. He is a clinician-scientist born and raised in Uganda with 25 years of professional experience working on health and poverty-related diseases in sub-Saharan Africa. This includes 21 years of work experience on medical product development and clinical regulatory activities. He holds a Medical Degree from Makerere University, Uganda, and has been in various clinical and research positions before and after undertaking a Master’s Degree at the University of Liverpool, and then a PhD at the Liverpool School of Tropical Medicine, United Kingdom. He is also a Fellow of the Royal College of Physicians of Edinburgh, Scotland.
I received medical general practitioner in 1986 and specialty in psychiatry in 1992 and fellowship in geriatric psychiatry and neuropsychiatry form University of Illinois at Chicago in 2000. I received certificate of Master of Business Administration in 2014 from Shahed University.
My main interests are 1. geriatric psychiatry. We have founded the first psychogeriatric unit in teaching general hospital of Rasoul Akram in 2018. Currently, one fellow is being training at Iran University of Medical Sciences.
The second one is suicide prevention. We have founded Iranian Scientific Society for Suicide prevention in 2015 (Irssp.iums.ac.ir). currently, we are conducting national suicide prevention programs.
Alain Marchand is full professor in the School of Industrial Relations at the University of Montreal, Canada, and a research associate at the Public Health Research Institute, University of Montreal (IRSPUM). He is the Director of the Research Team on Work and Mental Health (ERTSM), and he is in charge of the Social Determinants of Health research area at IRSPUM. Supported by grants from CIHR, SSHRC and FRQS, his research interests focused on the understanding and prevention of the role of occupation and pathogenic work organizations on the stress response, the occurrence of mental health problems, alcohol abuse, and the taking of psychotropic drugs.
Charlotte Marchandise is the civil society deputy Mayor for Health of the city of Rennes, France and President of the WHO Healthy Cities French Network. She is also co-chair of Global Urban Air Pollution Observatory (GUAPO). She has been working as an international expert, coordinator, communication officer and project manager in the corporate world and social and environmental NGOs. She defends a whole-of-government and whole-of-society approach and has developed a local policy of health promotion, health equity and environmental health with a systematic democratic point of view in order to empower inhabitants. She is an advocate for city diplomacy and health and works at organizing cooperation amongst cities, governments, universities, and the grassroots movements through collective intelligence and the Sustainable Development Goals global agenda.
David Margolis is Professor of Medicine, Microbiology and Immunology at the University of North Carolina at Chapel Hill. A molecular virologist and clinical investigator, his laboratory studies the interactions of HIV with its host, aiming to translate lab bench discoveries to the clinic to aid in the treatment of HIV. He is a fellow of the American College of Physicians, the Infectious Diseases Society of America, the American Society of Clinical Investigation, and an editorial board member of the Journal of Virology and AIDS, the journal of the International AIDS Society. Dr. Margolis is the leader of CARE: The Collaboratory of AIDS Researchers for Eradication. CARE is a New Vision for HIV Research. He also is the Director of the UNC HIV Cure Center, a partnership between UNC-CH and GlaxoSmithKline, an incredibly unique public-private partnership redefining the traditional way of conducting research and focused on finding a cure for HIV.
Bernardo Mariano Junior is the Chief Information Officer at the World Health Organization. In this role, he is responsible for coordinating WHO’s digital health vision and strategy. He leads and oversees all aspects of information technology, data security, and enterprise applications, ensuring WHO is advancing its digital capabilities to deliver its global health goals effectively.
Henrique Martins, MD, PhD. Studied Medicine and is an Internal Medicine Specialist. He obtained his PhD degree in Management from the Judge Business School, University of Cambridge. He has several publications in the area of management and informatics in healthcare. He currently works at SPMS as Chairman of the Board. SPMS is the Health Ministry Central Purchasing and IT authority. He was formerly the Chief Medical Information Officer (CMIO) of the Hospital Prof Dr Fernando Fonseca and later Adj.
Ana Paula Martins is the President of the Portuguese Pharmaceutical Society since 2016. She graduated in Pharmaceutical Sciences by University of Lisbon Faculty of Pharmacy in 1990. She also holds a Master Degree in Epidemiology by the New University of Lisbon Faculty of Medical Sciences (1995) and a PhD in Clinical Pharmacy by the University of Lisbon Faculty of Pharmacy (2005), where she is currently Assistant Professor at the Department of Social Pharmacy.
A member of the Independent Accountability Panel for EWEC, former Director of the department of Maternal, Newborn, Child and Adolescent Health at WHO HQ. Worked globally and in the African Region in clinical care and public health policy and programmes at all levels. Key areas of interest: improving quality of care and making health systems work for mothers and children. Qualified in Medicine from the University of Leeds, MPH LSHTM, Fellow FPHM, Hon. Professor LSHTM, UK, Hon. Fellow UCL, UK.
Trained in Internal Medicine and Nephrology in Switzerland, Australia, France, and the UK, she is still active as a Senior Consultant of Nephrology at the HUG and a member of the Swiss and the Paris Medical Association. She also holds a Master of Business Administration (MBA) degree from the University of Geneva with a focus on Health Economy and Policies.
Nanoot Mathurapote has been working at Thailand’s National Health Commission Office (NHCO) since 2008. As a head of Global Collaboration Unit, she is in charge of creating and expanding collaboration with international partners to advocate public participation in the policy process and health in all policies approach from Thailand’s experience namely the process of health assembly, health impact assessment and health charter. She has advocated public participation in the policy process and HiAP in many international conferences, e.g., WHO SEARO regional workshop on implementation of HiAP, WHO EMRO regional consultation on Urban Health: a Strategy for Reducing Health Inequities, Global Conference on Air Pollution and Health.
Lisa Matos is a Researcher and Clinical Psychology Doctoral Fellow at the William James Center for Research, ISPA-Lisbon. She has over 12 years of field experience in the US and Portugal working in the integration and rehabilitation of refugee populations, in particular survivors of torture. Ms. Matos has a BA in International Relations, an MA in Political Science and currently studies how refugees make meaning of past trauma and human rights violations thus achieving psychological adjustment.
Biologist, graduated in Biology (FCUL) and Ph.D. in Molecular Biology (King's College London). Senior researcher in Molecular Genetics at INIAV and President of the Portuguese Biologists Association (Ordem dos Biólogos) since 2014.
MSc in Computer Science Engineering and PhD in Computer Science and Biomedical Engineering. Tommaso leads the Bioinformatics Unit at Casa Sollievo della Sofferenza (FG) and CSS-Mendel (Rome), Italy, since July 2011. He was member of the Bioinformatics Italian Society (B.IT.S.) in 2007 and researcher at Microsoft Research-UNITN COSBI in January 2008. From October 2010 to July 2011, he was member of the Laboratory of Translational Genomics at CIBIO.
Jean Claude Mbanya (MD, PhD, MRCP (UK), FRCP (London)) is Professor of Medicine and Endocrinology at the Faculty of Medicine and Biomedical Sciences, University of Yaoundé I. He is Honorary President of the International Diabetes Federation. Output from his scientific research and service career has been published in 27 international book chapters and 185 papers indexed in peer-reviewed journals. He recipient of several international distinguished awards.
In this role, he is responsible for defining Pfizer’s public policy positions and advancing government and public affairs strategies internationally. Prior to this role, McCarthy was the Chief Counsel for Pfizer’s Worldwide Research and Development division and responsible for Pfizer's global Intellectual Property activities. He serves on the Boards of the Business Council for International Understanding, the Global Intellectual Property Center (GIPC), and the United States Council for International Business.
Dr. McNamara specializes in the recognition and understanding of the diseases of captive and free-ranging wildlife and is best known for her work on West she is credited as having “served a central role as a unifying force, molding and sometimes forcing interrelationships between local and federal government agencies and private enterprises, enabling progress toward the common goal of monitoring a newly emerging disease in the United States.”
Dr. Mehdi established and leads the Health Policy Initiative at the Indian Council for Research on International Economic Relations (ICRIER), New Delhi. He has more than 10 years of analytical and multidisciplinary research experience, focusing on a broad range of health and demographic issues – the process, design and analytical frame for assessment of health policies; prevention of chronic diseases along with the policy instruments and institutional design for its promotion; social determinants of health; the metrics and measurement of health inequities; health financing, governance and manpower; fertility and mortality patterns; demographic dividend; drug regulation. A couple of his books are in the pipeline – India Health Report 2018 (Oxford University Press), A shot of justice – 2 volumes (Oxford University Press), Chronic diseases in South Asia (Springer), Freedoms and fragility: The challenge of job creation in Kashmir, India (Routledge).
Sonal rose to the level of Chief Executive of Alliance India in October 2016, after serving in capacity of Director Programmes and Policy in the organisations for nine years. With three decades of experience in sexual health and development, Sonal guides Alliance India’s mission of community action for ending AIDS with a lot of programmatic experience and management smartness. Before joining Alliance India, Sonal was Challenge Fund Manager in the DFID programme that led to many path breaking interventions in India including brining oral substitution therapy for people who inject drugs. Prior to that she worked with organisations in India including NACO, Gujarat SACS, CHETNA and SEWA, as well as with the Pacific Institute of Women’s Health in Los Angeles, USA. Sonal has an MSW from the Faculty of Social Work, Vadodara, Gujarat. In a stride to continue learning, she has completed her International Masters in Practicing Management from McGill and has recently completed her Masters in Science in International Management from Lancaster, UK.
Director-General of the IPPF since 2011, he has more than 30 years of experience with organizations committed to sexual and reproductive health and rights for all, including his time as IPPF Africa Regional Director in Nairobi/ Kenya, where he worked between 2002 and 2011. Prior to working with IPPF, he held the position of Country Representative (Ethiopia) for Pathfinder International. He has a degree in Economics from the Catholic University in Louvain, Belgium.
Health System Manager, leader in program implementation with expertise in design and evaluation of health public policies, planning and strategic management of organizations. In his previous capacity as the Executive Secretary of the national HIV/AIDS response, he led negotiations with national, regional, continental and international organizations focused on health systems strengthening. He has written "The diagnosis of the access to social services and health in Guinea-Bissau".
Jean-Yves Mérindol is a professor of mathematics. His research publications focus on algebraic geometry, sociology and higher education history. He was advisor on school issues, higher education, research, and new technologies the various authorities, including the presidency of the French Republic.
Dr. Angela Merkel is the first female chancellor of Germany and one of the architects of the European Union. Dr. Merkel was born in Hamburg, Germany and studied physics at the University of Leipzig, earning a doctorate, and later worked as a chemist. After the fall of the Berlin Wall in 1989, Merkel joined the Christian Democratic Union (CDU) political party and was appointed to Helmut Kohl's cabinet as minister for women and youth. In 2000, Merkel was chosen party leader and won the 2005 election by just three seats. After the CDU agreed to a coalition deal with the Social Democrats (SPD) she was declared Germany's first female chancellor. She was elected to a second term in 2009, a third term in 2013 and a fourth term in 2017.
Fourth-year medical student at the Université de Montréal, Toby Messier founded OMEGA – Organization for Medical Education in Governance and Administration – with a group of fellow students in early 2015. He deepened his interest for management while working as a financial analyst. He now leads a research project exploring organizational optimisation trough intelligent software.
Earlier in his medical studies, Toby was responsible for partnerships for his university’s medical students’ association. He was also conducting research in the field of orthopedic surgery and was training as a high-level athlete in rowing.
Volker ter Meulen qualified as MD in 1960 and received a training in virology in the USA. A specialist in pediatrics and in clinical virology, he became a full professor in 1975 and Chairman of the Institute of Virology and Immunobiology at Wuerzburg University. He retired in 2002, having twice been elected Dean of the Faculty of Medicine. During his research career, ter Meulen worked on molecular and pathogenic aspects of viral infections in man and animals, in particular on infections of the central nervous system. Ter Meulen has also advised German research organisations and ministries on research topics and served internationally on committees of numerous organisations and scientific societies. From 2003-2010, ter Meulen was President of the German Academy of Sciences Leopoldina. From 2007-2010, he was President of the European Academies Science Advisory Council (EASAC). Since 2017, ter Meulen has been President of the IAP.
Former Director-General for International Cooperation in the National Health and Family Planning Commission of the People’s Republic of China, he has worked extensively on global health governance and has represented the government of China at a number of international fora. He was Vice-chair of WHO’s Executive Board, member of the UNAIDS Programme Coordinating Board, and representative of the Board of the Global Fund to Fight AIDS, TB and Malaria.
An advocate for innovation, Lloyd Minor has provided significant support for fundamental science and for clinical and translational research at Stanford. Before coming to Stanford, he was provost and senior vice president for academic affairs at Johns Hopkins University. In the medical community, Minor’s best known work includes his discovery of superior canal dehiscence syndrome.
The global advocate for Cancer Control and Non-Communicable Diseases has been Ambassador and Member of the Presidential Advisory Panel of the Union for International Cancer Control (UICC) since 2010. She is Honorary Chair of global steering committee for Tobacco Free Portfolios and Honorary President of Harvard University Global Task Force for Expanded Access to Cancer Control and Care in the Developing World. From 2002-2016, she was Director General of the King Hussein Cancer Foundation and from 2006-2016 Honorary Chairperson of Jordan Breast Cancer Program.
Benoît Miribel is the Director General of Fondation Mérieux; an organization dedicated to the fight against infectious diseases mainly in developing countries. He has also been the Honorary Chairman of Action against Hunger (ACF). He has chaired the Centre Français des Fonds et Foundations (CFF) and is also the president of Bioport; a humanitarian logistics platform in Lyon and the co-founder of the Forum Espace Humanitaire (FEH) of the bilingual journal, Humanitarian Alternatives, and a co-founding member of the association Friendship France, which operates in Bangladesh.
Christina Mitchell trained as a physician scientist specializing in clinical hematology. Her work for the last twenty years has focused on characterizing the function of unknown genes that regulate cell proliferation and growth, and when mutated or deleted lead to human disease.
Dr. Matshidiso Rebecca Moeti of Botswana was elected WHO Regional Director for Africa in 2015. She is the first woman to hold the position. Dr. Moeti aims to build a responsive, effective and result-driven regional secretariat that can advance efforts towards universal health coverage and accelerate progress toward global development goals, while tackling emerging threats. Strong partnerships will underpin every aspect of the Regional Office's work during her tenure. Dr. Moeti is a public health veteran, with more than 35 years of national and international experience. She joined WHO’s Africa Regional Office in 1999 and has served as Deputy Regional Director, Assistant Regional Director, Director of Noncommunicable Diseases, WHO Representative for Malawi, and Coordinator of the Inter-Country Support Team for the South and East African countries.
Dr. Geneviève Moineau, MD, FRCPC, is President and CEO of the Association of Faculties of Medicine of Canada (AFMC). She previously served as Associate Dean, Undergraduate Medical Education, at the University of Ottawa Faculty of Medicine. She practices Pediatric Emergency Medicine at the Children’s Hospital of Eastern Ontario. Dr Moineau joined the AFMC in 2011 as VP Education and Secretary to CACMS and CACME. Since 2013 as President and CEO, she has led the development of a memorandum of understanding with the Association of American Medical Colleges (AAMC), the American Medical Association, and the Canadian Medical Association on the Canadianization of medical school accreditation, has initiated the transfer of the Canadian Graduation Questionnaire and all AAMC data on Canadians to the AFMC, and has supported the implementation of the AFMC Student Portal. She has also recently negotiated a collaboration agreement with the Conférence Internationale des Doyens et des Facultés de Médecine d’Expression Française (CIDMEF).
Nathalie Moll is the Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA). EFPIA represents the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world. Nathalie previously worked as the Secretary General of EuropaBio ranked as the most effective European Trade Association in Brussels in 2013. After graduating with Honours in Biochemistry and Biotechnology from St Andrews University, Scotland, and a stage at the European Commission, Nathalie has spent 20 years working for the biotech industry at EU and national level in associations and corporate positions. Within EuropaBio, Nathalie held the posts of External Relations Manager, Director for Strategic Policy, Director for Healthcare Biotech, Director for Agricultural Biotech sector and was the Secretary General from 2010 to 2017. Nathalie, who held the position of Vice Chair of the International Council of Biotech Associations (ICBA) since its inception in 2014 to 2016, was elected Chair of the ICBA in June 2016 for a 2 year term. In 2013, Nathalie won the Technovisionaries Women Innovation Award organised by Women & Technologies® while in 2009, Nathalie and the Green Biotech Team at EuropaBio were presented with the Leadership and Excellence in Advancing Ag-Biotech and Food Issues Award. Nathalie was also named one of the 15 leading women in biotech in Europe in 2017.
Bernd Montag, Ph.D., has been CEO of Siemens Healthineers since February 2015. As of March 2018, the company is listed on the Frankfurt Stock Exchange as Siemens Healthineers AG (SHL). Three months after its stock market debut, Siemens Healthineers entered the technology index TecDAX and in September that year Deutsche Börse also included the company in the mid-cap index MDAX. Bernd Montag joined Siemens in 1995, after completion of his studies in Physics at the Friedrich-Alexander-University, Erlangen-Nuremberg, and earning a Ph.D. in theoretical multi-particle physics. He held positions in corporate quality management and sales in the hearing aid division before moving to imaging systems in 1999, where he served as a product manager for computed tomography and as the head of marketing for magnetic resonance business. In 2004, he assumed overall responsibility for computed tomography, and in 2008, he was named President of the Imaging & Therapy Division, which combined the overall business of diagnostic imaging and image-guided therapies.
Her work focuses on global governance, the political economy of global health, the evolution of international regimes, and innovative policies for addressing global problems. Prior to coming to Harvard, she worked for the Médecins Sans Frontières/Doctors Without Borders (MSF) international Campaign for Access to Essential Medicines, and consulted for a number of non-governmental organizations, think tanks, and intergovernmental organizations on global governance and access to medicines issues.
Glen Moriarty is a psychologist who marries his background in psychology with his love for technology. He is driven to reduce health disparities and ensure emotional support to underserved populations worldwide. His career has been dedicated to supporting people in need, decreasing human suffering and reducing economic burden. As the CEO, he has lead 7 Cups in raising over 18m in funding (seed + innovation grant), and ushered in dozens of significant contracts across private, non-profit, university and government partners. Moriarty feels that serving vulnerable populations is key to solving broader health challenges and has aligned reach with revenue to maximize impact. His stewardship and leadership has led to 7 Cups reaching 39 million people in 189 countries in less than five years.
He holds the Canada Research Chair in Hematopoiesis and Immune Cell Differentiation and is Full Research Professor at the University of Montreal and Adjunct Professor at McGill University. Until 2006, he held several senior management positions in Germany. He is member of the Board of Directors of the Canadian Society for Molecular Biosciences (CSBM) and Research Canada.
Mirfin Mpundu is the Executive Director of the Ecumenical Pharmaceutical Network (EPN), Coordinator for the Action Against Antibiotic Resistance (ReAct) Africa Node, and Program Manager for the Empowerment, Engagement and Network (EEE) Program of ReAct. He is a registered pharmacist in the USA and public health specialist with more than 20 years extensive experience in pharmaceutical systems, supply chain management; pooled procurement and procurement contract management. His experience also includes achievement in consultancy advice and technical assistance provision in procurement and health product supply, quality assurance management for African health systems and global level experience and achievement in leadership in public health procurement and supply system practice and capacity building and skills transfer. He is a frequent participant and presenter on current pharmaceutical global issues including antibiotic and antimicrobial resistance, Non-communicable diseases and supply chain management. Mirfin holds a Master’s Degree in Public Health, Masters in Business Administration, and a Degree in Pharmacy.
Prior to his current post, Gerd Müller held positions as Parliamentary State Secretary to the Federal Minister of Food, Agriculture, and Consumer Protection and Deputy Head of the Office for Foreign Relations of the Hanns Seidel Foundation. He holds a master's degree in business education.
He leads the foundation’s efforts in research and development of vaccines, drugs, and diagnostics to address major global health challenges in the developing world. He oversees the foundation’s strategies in HIV, tuberculosis, malaria, pneumonia, diarrheal disease, enteric and diarrheal diseases, and neglected infectious diseases. Prior to joining the foundation in 2011, he was global head of development with Novartis, and previously was involved in clinical research at Pfizer and Parke-Davis.
Marie Munoz-Bertrand is a family physician engaged in offering a dignified access to healthcare to populations in situations of extreme vulnerability often on the margin of the healthcare system. She has a broad experience with asylum seekers and refugees, uninsured migrants, persons living with HIV/AIDS as well as with populations affected by humanitarian crises which she has developed in her clinical activities and in missions with international organizations. Beyond her clinical activities, Dr Munoz-Bertrand advocates with Médecins du Monde for the right to health care for all regardless of immigration status and socio-economic status. She holds a B.Sc. in anthropology, an MD and a Master’s of Public Health from the University of Montreal.
Dr. Heikki Murtomaa is professor emeritus and head of the department of Oral Public Health at the University of Helsinki, Finland. He is the author several text books and numerous scientific publications. He has supervised 25 doctoral theses and lectured on different international forums. Dr. Murtomaa has worked as a WHO consultant on several occasions. He has previously been the president of the Association for Dental Education in Europe and a board member of International Federation of Dental Educators and Associations. Dr. Murtomaa is currently the visiting professor at the Kyushu Dental University, Japan and Tehran University of Medical Health Sciences, Iran.
Mohammadreza Naderian is cardiology resident in Tehran Hear Center, and graduated from MD, MPH in 2017 from Tehran University of Medical Sciences. He published two books and more than 30 articles in the field of medicine and public health, and participated as a designer or executer in more than 10 national and international health-related projects. He has achieved three national awards in the medical education festivals and elected as the national outstanding students in 2018. In the 7th regional meeting of World Health Summit, he is a member of student steering committee and responsible for the drafting of the constitutions for “M8-Alliance Student Network”.
David M. Nathan, MD, is currently Director of the Clinical Research Center and of the Diabetes Center at Massachusetts General Hospital, and a Professor of Medicine at Harvard Medical School. Dr. Nathan focuses on the development of innovative therapies to prevent and treat type 1 and type 2 diabetes and to prevent their long-term complications. Dr. Nathan was one of the architects of the landmark Diabetes Control and Complications Trial and chairs its long-term follow-up. Dr. Nathan also chairs the multi-center NIH Diabetes Prevention Program and the GRADE Comparative Effectiveness Study of the treatment of type 2 diabetes. Dr. Nathan led the international Expert Committee on the Diagnosis of Diabetes. With more than 500 publications, Dr. Nathan is an internationally recognized expert on diabetes. He was awarded the Outstanding Clinician Award by the American Diabetes Association in 2002, its Outstanding Achievement in Clinical Diabetes Research Award in 2015 and the Distinguished Scientist Award by the National Institute of Diabetes Digestive and Kidney Disease, NIH, in 2010.
Ameet Nathwani has more than twenty years’ experience in the pharmaceutical industry, beginning in 1994 when he joined Glaxo Group Research. Between 1994 and 2004 he held increasingly senior functional and franchise leadership roles in research and development in Glaxo, SmithKline Beecham and GlaxoSmithKline, in Europe and the US. He joined Novartis in 2004 as Senior Vice President and Global Development Head of the Cardiovascular and Metabolic Franchise, and over an 11-year period held a number of senior development and commercial positions including Global Head of the Critical Care Franchise. In June 2014 Ameet Nathwani was appointed Global Head of Medical Affairs at Novartis Pharma AG and became a member of the Pharma Executive Committee, where he led the establishment of a Real World Evidence Center of Excellence and piloted the Digital Medicine strategy. He was appointed as Chief Medical Officer and Executive Vice President Medical Function in May 2016. In addition to this role, he was appointed Chief Digital Officer on February 12, 2019. Ameet Nathwani is a citizen of the United Kingdom.
Barbara Natterson-Horowitz, M.D., develops bio-inspired strategies for understanding and addressing human health challenges. Her work focuses on the natural world and evolutionary biology as sources of insight for health and development. A Visiting Professor in Harvard University’s Department of Human Evolutionary Biology and Professor of Medicine in the UCLA Division of Cardiology, she co-directs the UCLA Evolutionary Medicine Program. Studying a diverse range of animals in natural settings she has uncovered evolved adaptations with relevance to heart failure, sudden cardiac death, seizures, dementia, movement disorders, infertility and psychiatric conditions including anxiety, compulsive and eating disorders.